| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.52e-05 | 130 | 247 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.10e-05 | 18 | 247 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.51e-04 | 65 | 247 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.52e-04 | 2 | 247 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.70e-04 | 28 | 247 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | sulfurtransferase activity | 3.79e-04 | 12 | 247 | 3 | GO:0016783 | |
| GeneOntologyBiologicalProcess | neuron development | LGR4 CDH23 ADGRV1 NRP1 HMCN2 ALMS1 PTPRM TUBA1A UBE3A PTPRS GORASP1 UGCG STRC SLITRK6 TSC22D4 STRCP1 CACNA1A FAT4 HTR7 SZT2 TNC FAT3 SMURF1 RAPGEF1 RET LMO4 OGDH NTN4 TH TENM3 AVIL CSPG4 TENM1 LRP1 UBA6 MTR RTN4RL2 TNR TOP2B | 2.03e-06 | 1463 | 247 | 39 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | LGR4 CDH23 ADGRV1 NRP1 HMCN2 ALMS1 PTPRM TUBA1A UBE3A PTPRS GORASP1 STRC SLITRK6 TSC22D4 STRCP1 CACNA1A FAT4 HTR7 SZT2 TNC FAT3 SMURF1 RAPGEF1 RET LMO4 NTN4 TENM3 AVIL CSPG4 LRP1 UBA6 MTR RTN4RL2 TNR TOP2B | 4.54e-06 | 1285 | 247 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 1.86e-05 | 28 | 247 | 5 | GO:0046339 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | ITGA9 FREM1 NRP1 PTPRJ PIK3CB STRC STRCP1 NID2 SORBS1 TEK EMILIN1 LRP1 CD96 | 2.43e-05 | 270 | 247 | 13 | GO:0007160 |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.70e-05 | 73 | 247 | 7 | GO:0060119 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 3.98e-05 | 53 | 247 | 6 | GO:0060122 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYO10 LGR4 CDH23 ADD1 STRIP2 BAP1 NRP1 HMCN2 SSH1 PTPRJ PTPRM TUBA1A UBE3A PTPRS GORASP1 STRC SLITRK6 TSC22D4 ALDOA STRCP1 CACNA1A SZT2 FAT3 SMURF1 RET LMO4 NTN4 CDH22 LRP1 TNR TOP2B | 4.20e-05 | 1194 | 247 | 31 | GO:0000902 |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 8.36e-05 | 20 | 247 | 4 | GO:0044406 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 8.96e-05 | 187 | 247 | 10 | GO:0007156 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 1.07e-04 | 63 | 247 | 6 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 1.07e-04 | 63 | 247 | 6 | GO:0046463 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDH23 HMCN2 PTPRM PTPRS PIK3CB ADGRL3 FAT4 FAT3 PCDHAC1 RET CDH22 TENM3 TENM1 | 1.10e-04 | 313 | 247 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 1.11e-04 | 40 | 247 | 5 | GO:0000096 | |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB4 CARMIL3 SIX4 ADD1 NRP1 HMCN2 SSH1 PTPRJ TUBA1A PARD6A UBE3A PTPRS GJD3 SLITRK6 ADGRL3 UNC13B CACNA1A TNC RAPGEF1 DGKZ SORBS1 TEK CDH22 TENM3 LRP1 TNR | 1.17e-04 | 974 | 247 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | GAS6 ITGA9 FREM1 NRP1 PTPRJ PIK3CB STRC STRCP1 NID2 SORBS1 TEK EMILIN1 NTN4 LRP1 CD96 | 1.36e-04 | 410 | 247 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.56e-04 | 96 | 247 | 7 | GO:0060113 | |
| GeneOntologyBiologicalProcess | axon regeneration | 1.77e-04 | 69 | 247 | 6 | GO:0031103 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 1.89e-04 | 99 | 247 | 7 | GO:0050766 | |
| GeneOntologyBiologicalProcess | diacylglycerol biosynthetic process | 1.91e-04 | 10 | 247 | 3 | GO:0006651 | |
| GeneOntologyBiologicalProcess | cobalamin metabolic process | 1.91e-04 | 10 | 247 | 3 | GO:0009235 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 2.07e-04 | 71 | 247 | 6 | GO:0048008 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 2.57e-04 | 104 | 247 | 7 | GO:0042490 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | MAN2A1 ABR CDH23 SIX4 ALMS1 PTPRM STRC SLITRK6 STRCP1 COL5A1 FAT3 TH TENM3 | 2.69e-04 | 343 | 247 | 13 | GO:0090596 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | LGR4 CDH23 NRP1 HMCN2 PTPRM UBE3A PTPRS GORASP1 STRC SLITRK6 STRCP1 CACNA1A SZT2 FAT3 SMURF1 RET LMO4 NTN4 LRP1 TNR TOP2B | 2.78e-04 | 748 | 247 | 21 | GO:0048667 |
| Domain | Alpha_tubulin | 1.92e-12 | 9 | 241 | 7 | IPR002452 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 7.89e-09 | 22 | 241 | 7 | IPR018316 | |
| Domain | Tubulin_C | 7.89e-09 | 22 | 241 | 7 | SM00865 | |
| Domain | Tubulin_C | 7.89e-09 | 22 | 241 | 7 | PF03953 | |
| Domain | Tubulin_C | 1.12e-08 | 23 | 241 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.12e-08 | 23 | 241 | 7 | PS00227 | |
| Domain | Tubulin | 1.12e-08 | 23 | 241 | 7 | SM00864 | |
| Domain | Tub_FtsZ_C | 1.12e-08 | 23 | 241 | 7 | IPR008280 | |
| Domain | Tubulin | 1.12e-08 | 23 | 241 | 7 | IPR000217 | |
| Domain | Tubulin_CS | 1.12e-08 | 23 | 241 | 7 | IPR017975 | |
| Domain | EGF_3 | GAS6 LRP1B STAB1 HMCN2 NID2 FAT4 TNC FAT3 CUBN TEK OIT3 TENM3 TENM1 LRP1 ADAM2 TNR MASP2 | 1.13e-08 | 235 | 241 | 17 | PS50026 |
| Domain | Tubulin_FtsZ_GTPase | 1.57e-08 | 24 | 241 | 7 | IPR003008 | |
| Domain | Tubulin | 1.57e-08 | 24 | 241 | 7 | PF00091 | |
| Domain | EGF-like_dom | GAS6 LRP1B STAB1 HMCN2 NID2 FAT4 FRAS1 TNC FAT3 CUBN TEK OIT3 TENM3 TENM1 LRP1 TNR MASP2 | 2.66e-08 | 249 | 241 | 17 | IPR000742 |
| Domain | EGF_1 | GAS6 LRP1B STAB1 HMCN2 FAT4 TNC FAT3 CUBN TEK NTN4 OIT3 TENM3 TENM1 LRP1 ADAM2 TNR MASP2 | 3.78e-08 | 255 | 241 | 17 | PS00022 |
| Domain | EGF_2 | GAS6 LRP1B STAB1 HMCN2 NID2 FAT4 TNC FAT3 CUBN TEK OIT3 TENM3 TENM1 LRP1 ADAM2 TNR MASP2 | 6.62e-08 | 265 | 241 | 17 | PS01186 |
| Domain | EGF | GAS6 LRP1B STAB1 NID2 FAT4 FRAS1 TNC FAT3 CUBN TEK OIT3 TENM3 TENM1 LRP1 TNR MASP2 | 7.19e-08 | 235 | 241 | 16 | SM00181 |
| Domain | Growth_fac_rcpt_ | ERBB4 GAS6 LRP1B STAB1 HMCN2 NID2 FAT4 FRAS1 TNC CUBN TEK NTN4 LRP1 | 1.21e-07 | 156 | 241 | 13 | IPR009030 |
| Domain | - | 1.45e-07 | 20 | 241 | 6 | 3.30.1330.20 | |
| Domain | - | 2.00e-07 | 21 | 241 | 6 | 1.10.287.600 | |
| Domain | - | 2.72e-07 | 22 | 241 | 6 | 3.40.50.1440 | |
| Domain | EGF-like_CS | GAS6 LRP1B STAB1 HMCN2 NID2 FAT4 TNC FAT3 CUBN TEK NTN4 TENM3 TENM1 LRP1 TNR MASP2 | 3.02e-07 | 261 | 241 | 16 | IPR013032 |
| Domain | EGF_Ca-bd_CS | 5.00e-07 | 97 | 241 | 10 | IPR018097 | |
| Domain | EGF_CA | 5.24e-07 | 122 | 241 | 11 | SM00179 | |
| Domain | EGF_CA | 6.06e-07 | 99 | 241 | 10 | PS01187 | |
| Domain | EGF-like_Ca-bd_dom | 6.17e-07 | 124 | 241 | 11 | IPR001881 | |
| Domain | ASX_HYDROXYL | 6.65e-07 | 100 | 241 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.14e-06 | 106 | 241 | 10 | IPR000152 | |
| Domain | EGF_CA | 1.66e-06 | 86 | 241 | 9 | PF07645 | |
| Domain | DHC_N1 | 1.82e-06 | 8 | 241 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.82e-06 | 8 | 241 | 4 | IPR013594 | |
| Domain | - | 9.91e-06 | 39 | 241 | 6 | 2.120.10.30 | |
| Domain | EGF_extracell | 1.18e-05 | 60 | 241 | 7 | IPR013111 | |
| Domain | EGF_2 | 1.18e-05 | 60 | 241 | 7 | PF07974 | |
| Domain | YD | 2.08e-05 | 5 | 241 | 3 | IPR006530 | |
| Domain | ATPase_dyneun-rel_AAA | 2.45e-05 | 14 | 241 | 4 | IPR011704 | |
| Domain | MT | 2.45e-05 | 14 | 241 | 4 | PF12777 | |
| Domain | AAA_8 | 2.45e-05 | 14 | 241 | 4 | PF12780 | |
| Domain | AAA_5 | 2.45e-05 | 14 | 241 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.45e-05 | 14 | 241 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.45e-05 | 14 | 241 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.45e-05 | 14 | 241 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.45e-05 | 14 | 241 | 4 | PF08393 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.64e-05 | 46 | 241 | 6 | IPR011042 | |
| Domain | DHC_fam | 3.30e-05 | 15 | 241 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.30e-05 | 15 | 241 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.30e-05 | 15 | 241 | 4 | IPR004273 | |
| Domain | Gal_mutarotase_SF_dom | 5.64e-05 | 17 | 241 | 4 | IPR011013 | |
| Domain | LAM_G_DOMAIN | 1.22e-04 | 38 | 241 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 1.56e-04 | 40 | 241 | 5 | PF02210 | |
| Domain | DUF5050 | 1.66e-04 | 2 | 241 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.66e-04 | 2 | 241 | 2 | PF16472 | |
| Domain | Calx_beta | 1.68e-04 | 9 | 241 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.68e-04 | 9 | 241 | 3 | PF03160 | |
| Domain | LamG | 2.47e-04 | 44 | 241 | 5 | SM00282 | |
| Domain | cEGF | 3.23e-04 | 26 | 241 | 4 | PF12662 | |
| Domain | cEGF | 3.23e-04 | 26 | 241 | 4 | IPR026823 | |
| Domain | CRAL_TRIO_N | 3.24e-04 | 11 | 241 | 3 | PF03765 | |
| Domain | - | 3.76e-04 | 27 | 241 | 4 | 3.30.160.20 | |
| Domain | CRAL-bd_toc_tran | 4.28e-04 | 12 | 241 | 3 | IPR001071 | |
| Domain | EGF_dom | 4.28e-04 | 12 | 241 | 3 | IPR024731 | |
| Domain | EGF_3 | 4.28e-04 | 12 | 241 | 3 | PF12947 | |
| Domain | CRAL_TRIO_N | 4.28e-04 | 12 | 241 | 3 | SM01100 | |
| Domain | dsRBD_dom | 4.34e-04 | 28 | 241 | 4 | IPR014720 | |
| Domain | - | 4.93e-04 | 3 | 241 | 2 | 2.70.98.20 | |
| Domain | Cse1 | 4.93e-04 | 3 | 241 | 2 | PF08506 | |
| Domain | COPPER_AMINE_OXID_1 | 4.93e-04 | 3 | 241 | 2 | PS01164 | |
| Domain | COPPER_AMINE_OXID_2 | 4.93e-04 | 3 | 241 | 2 | PS01165 | |
| Domain | Cse1 | 4.93e-04 | 3 | 241 | 2 | IPR013713 | |
| Domain | Cu_amine_oxid | 4.93e-04 | 3 | 241 | 2 | PF01179 | |
| Domain | Cu_amine_oxidase_N3 | 4.93e-04 | 3 | 241 | 2 | IPR015802 | |
| Domain | Cu_amine_oxidase_N2 | 4.93e-04 | 3 | 241 | 2 | IPR015800 | |
| Domain | Cu_amine_oxidN2 | 4.93e-04 | 3 | 241 | 2 | PF02727 | |
| Domain | Cu_amine_oxidN3 | 4.93e-04 | 3 | 241 | 2 | PF02728 | |
| Domain | Cu_amine_oxidase_N-reg | 4.93e-04 | 3 | 241 | 2 | IPR016182 | |
| Domain | Cu_amine_oxidase_C | 4.93e-04 | 3 | 241 | 2 | IPR015798 | |
| Domain | ConA-like_dom | 5.75e-04 | 219 | 241 | 10 | IPR013320 | |
| Domain | Ldl_recept_b | 6.95e-04 | 14 | 241 | 3 | PF00058 | |
| Domain | LDLRB | 6.95e-04 | 14 | 241 | 3 | PS51120 | |
| Domain | Cadherin | 8.55e-04 | 118 | 241 | 7 | IPR002126 | |
| Domain | LY | 8.61e-04 | 15 | 241 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 8.61e-04 | 15 | 241 | 3 | IPR000033 | |
| Domain | CRAL/TRIO_N_dom | 8.61e-04 | 15 | 241 | 3 | IPR011074 | |
| Domain | Laminin_G | 9.01e-04 | 58 | 241 | 5 | IPR001791 | |
| Domain | Tox-GHH_dom | 9.78e-04 | 4 | 241 | 2 | IPR028916 | |
| Domain | Gal_mutarotase_N | 9.78e-04 | 4 | 241 | 2 | IPR031727 | |
| Domain | Tox-GHH | 9.78e-04 | 4 | 241 | 2 | PF15636 | |
| Domain | NIDOGEN_G2 | 9.78e-04 | 4 | 241 | 2 | PS50993 | |
| Domain | Ten_N | 9.78e-04 | 4 | 241 | 2 | PF06484 | |
| Domain | TENEURIN_N | 9.78e-04 | 4 | 241 | 2 | PS51361 | |
| Domain | G2_nidogen/fibulin_G2F | 9.78e-04 | 4 | 241 | 2 | IPR006605 | |
| Domain | G2F | 9.78e-04 | 4 | 241 | 2 | PF07474 | |
| Domain | GFP | 9.78e-04 | 4 | 241 | 2 | IPR009017 | |
| Domain | Ten_N | 9.78e-04 | 4 | 241 | 2 | IPR009471 | |
| Domain | NtCtMGAM_N | 9.78e-04 | 4 | 241 | 2 | PF16863 | |
| Domain | Cu_amine_oxidase | 9.78e-04 | 4 | 241 | 2 | IPR000269 | |
| Domain | MAM_1 | 1.05e-03 | 16 | 241 | 3 | PS00740 | |
| Domain | EGF | 1.26e-03 | 126 | 241 | 7 | PF00008 | |
| Domain | MAM | 1.26e-03 | 17 | 241 | 3 | SM00137 | |
| Domain | - | 1.45e-03 | 95 | 241 | 6 | 2.60.120.200 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.97e-11 | 17 | 189 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.51e-11 | 18 | 189 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.00e-11 | 19 | 189 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.00e-11 | 19 | 189 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 9.88e-11 | 20 | 189 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 9.88e-11 | 20 | 189 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.58e-10 | 21 | 189 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.58e-10 | 21 | 189 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 DYNC2H1 TUBA3D TUBA1C | 1.93e-10 | 43 | 189 | 10 | M47773 |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH9 TUBA3D TUBA1C DNAH11 | 1.93e-10 | 43 | 189 | 10 | M47669 |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.45e-10 | 22 | 189 | 8 | M47903 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH9 TUBA3D TUBA1C DNAH11 | 3.14e-10 | 45 | 189 | 10 | M47670 |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.72e-10 | 23 | 189 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.72e-10 | 23 | 189 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.72e-10 | 23 | 189 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 5.51e-10 | 24 | 189 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.51e-10 | 24 | 189 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 8.01e-10 | 25 | 189 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.01e-10 | 25 | 189 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.14e-09 | 26 | 189 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.14e-09 | 26 | 189 | 8 | M47672 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.35e-09 | 38 | 189 | 9 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 2.22e-09 | 28 | 189 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 3.04e-09 | 29 | 189 | 8 | M27948 | |
| Pathway | REACTOME_AGGREPHAGY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 5.47e-09 | 44 | 189 | 9 | M29830 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 7.19e-09 | 32 | 189 | 8 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.19e-09 | 32 | 189 | 8 | M29848 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 9.38e-09 | 33 | 189 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 9.38e-09 | 33 | 189 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.55e-08 | 35 | 189 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.17e-08 | 51 | 189 | 9 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 3.08e-08 | 53 | 189 | 9 | M27651 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | TUBA3E PSMD2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A UBE2J1 TUBA3D TUBA1C | 3.36e-08 | 71 | 189 | 10 | M39690 |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.87e-08 | 17 | 189 | 6 | MM14731 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 5.98e-08 | 57 | 189 | 9 | M27251 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | TUBA3E TUBA8 ADAR TUBA4A TUBA3C DHX9 TUBA1B TUBA1A TUBA3D TUBA1C | 6.56e-08 | 76 | 189 | 10 | M48037 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | TUBA3E PSMD2 TUBA8 TUBA4A TUBA3C TUBA1B PSME4 TUBA1A TUBA3D TUBA1C | 9.56e-08 | 79 | 189 | 10 | M27743 |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.06e-07 | 44 | 189 | 8 | M27934 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GORASP1 DYNC1H1 COPA TUBA3D TUBA1C | 1.16e-07 | 102 | 189 | 11 | M27648 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.52e-07 | 46 | 189 | 8 | M27828 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.77e-07 | 32 | 189 | 7 | MM14730 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.78e-07 | 20 | 189 | 6 | MM1383 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.54e-07 | 49 | 189 | 8 | M891 | |
| Pathway | REACTOME_AGGREPHAGY | 4.19e-07 | 36 | 189 | 7 | MM15669 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A DYNC1H1 TUBA3D TUBA1C | 5.57e-07 | 95 | 189 | 10 | M6729 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.40e-07 | 55 | 189 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 7.38e-07 | 56 | 189 | 8 | M2333 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.26e-06 | 27 | 189 | 6 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.26e-06 | 27 | 189 | 6 | MM15549 | |
| Pathway | REACTOME_KINESINS | 1.44e-06 | 61 | 189 | 8 | M977 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.76e-06 | 44 | 189 | 7 | MM14606 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.97e-06 | 29 | 189 | 6 | MM15219 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.66e-06 | 66 | 189 | 8 | MM17074 | |
| Pathway | KEGG_GAP_JUNCTION | PDGFRB TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 3.21e-06 | 90 | 189 | 9 | M4013 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 3.21e-06 | 90 | 189 | 9 | M29841 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.22e-06 | 48 | 189 | 7 | MM15353 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.35e-06 | 68 | 189 | 8 | MM14968 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | ERBB4 GLS2 GABRQ TUBA3E BCHE TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A UNC13B CACNA1A TUBA3D TUBA1C SLC22A2 | 3.59e-06 | 270 | 189 | 15 | M15514 |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | ERBB4 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 4.61e-06 | 94 | 189 | 9 | M2843 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E TUBA8 ITGA9 TUBA4A TUBA3C NRP1 TUBA1B TUBA1A TUBA3D TUBA1C | 5.16e-06 | 121 | 189 | 10 | M872 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 5.18e-06 | 72 | 189 | 8 | M26954 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.60e-06 | 52 | 189 | 7 | MM14949 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.75e-06 | 73 | 189 | 8 | MM15491 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 7.25e-06 | 54 | 189 | 7 | M27482 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | CTSF TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 7.42e-06 | 126 | 189 | 10 | M705 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.70e-06 | 100 | 189 | 9 | M27650 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 7.79e-06 | 76 | 189 | 8 | M27215 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GORASP1 DYNC1H1 COPA TUBA3D TUBA1C | 8.09e-06 | 156 | 189 | 11 | M27097 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | MAN2A1 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GORASP1 DYNC1H1 COPA TUBA3D TUBA1C | 8.21e-06 | 187 | 189 | 12 | M961 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.83e-06 | 37 | 189 | 6 | MM15102 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 COPA TUBA3D TUBA1C | 1.28e-05 | 134 | 189 | 10 | M27751 |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | TUBA3E PSMD2 TUBA8 TUBA4A TUBA3C TUBA1B PSME4 ALMS1 TUBA1A DYNC1H1 TUBA3D TUBA1C | 1.62e-05 | 200 | 189 | 12 | M864 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | TUBA8 TUBA4A TUBA1B TUBA1A GORASP1 DYNC1H1 COPA TUBA3D TUBA1C | 1.68e-05 | 110 | 189 | 9 | MM15350 |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | MAN2A1 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 COPA TUBA3D TUBA1C IGF2R | 1.88e-05 | 203 | 189 | 12 | M27654 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | PSMD2 TUBA4A TUBA3C TUBA1B PSME4 TUBA1A DYNC2H1 TUBA3D TUBA1C | 2.08e-05 | 113 | 189 | 9 | M27471 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.73e-05 | 90 | 189 | 8 | MM14979 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | PSMD2 TUBA4A TUBA3C TUBA1B PSME4 TUBA1A DYNC2H1 TUBA3D TUBA1C SMURF1 | 3.41e-05 | 150 | 189 | 10 | M27440 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA8 ADAR TUBA4A TUBA3C DHX9 TUBA1B TUBA1A TUBA3D TUBA1C | 3.61e-05 | 151 | 189 | 10 | M550 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.75e-05 | 94 | 189 | 8 | MM14515 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ERBB4 GLS2 GABRQ TUBA3E BCHE TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PTPRS SLITRK6 UNC13B CACNA1A TUBA3D TUBA1C SLC22A2 | 3.89e-05 | 411 | 189 | 17 | M735 |
| Pathway | REACTOME_PROTEIN_FOLDING | 5.06e-05 | 98 | 189 | 8 | M776 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3E PSMD2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PIK3CB CACNA1D TUBA3D TUBA1C LRP1 HSD17B10 | 5.10e-05 | 261 | 189 | 13 | M42565 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 5.26e-05 | 127 | 189 | 9 | M27181 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | TUBA3E PSMD2 TUBA8 TUBA4A TUBA3C TUBA1B PSME4 TUBA1A DYNC1H1 TUBA3D TUBA1C | 5.34e-05 | 191 | 189 | 11 | M29614 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.38e-05 | 73 | 189 | 7 | MM15672 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.54e-05 | 52 | 189 | 6 | MM15211 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | MAN2A1 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A GORASP1 DYNC1H1 COPA TUBA3D TUBA1C PDIA3 ST6GALNAC2 | 6.83e-05 | 307 | 189 | 14 | M894 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 8.27e-05 | 18 | 189 | 4 | M225 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 8.28e-05 | 105 | 189 | 8 | MM15206 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A DYNC1H1 DYNC2H1 TUBA3D TUBA1C | 8.47e-05 | 201 | 189 | 11 | M27472 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYO10 TRPC3 TUBA3E PSMD2 ADGRV1 TUBA8 ITGA9 TUBA4A TUBA3C NRP1 TUBA1B PSME4 TUBA1A PIK3CB CACNA1D COL5A1 TUBA3D TUBA1C RET NTN4 | 9.19e-05 | 575 | 189 | 20 | M29853 |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | PSMD2 TUBA4A TUBA1B PSME4 TUBA1A DYNC2H1 TUBA3D TUBA1C SMURF1 | 9.48e-05 | 137 | 189 | 9 | MM15182 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3E TUBA8 NEK9 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A DYNC1H1 TUBA3D TUBA1C | 9.66e-05 | 204 | 189 | 11 | M4217 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 1.00e-04 | 138 | 189 | 9 | M29805 |
| Pathway | REACTOME_KINESINS | 1.10e-04 | 57 | 189 | 6 | MM15714 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 1.12e-04 | 140 | 189 | 9 | M27550 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.66e-04 | 116 | 189 | 8 | MM14855 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | PSMD2 TUBA8 TUBA4A TUBA1B PSME4 ALMS1 TUBA1A DYNC1H1 TUBA3D TUBA1C | 1.88e-04 | 184 | 189 | 10 | MM15145 |
| Pathway | REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM | 1.90e-04 | 22 | 189 | 4 | M27243 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBA8 ITGA9 TUBA4A NRP1 TUBA1B TUBA1A PIK3CB COL5A1 TUBA3D TUBA1C RET NTN4 | 2.11e-04 | 261 | 189 | 12 | MM15676 |
| Pubmed | 5.34e-17 | 9 | 248 | 8 | 21167302 | ||
| Pubmed | 4.22e-13 | 19 | 248 | 8 | 15698476 | ||
| Pubmed | 4.22e-13 | 19 | 248 | 8 | 15691386 | ||
| Pubmed | 1.75e-12 | 22 | 248 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 3.42e-12 | 8 | 248 | 6 | 16148047 | |
| Pubmed | 1.06e-10 | 6 | 248 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.06e-10 | 6 | 248 | 5 | 7651436 | |
| Pubmed | 1.06e-10 | 6 | 248 | 5 | 16327313 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.10e-10 | 12 | 248 | 6 | 15331610 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.34e-10 | 22 | 248 | 7 | 23826228 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 2.04e-10 | 13 | 248 | 6 | 10908577 | |
| Pubmed | 3.54e-10 | 14 | 248 | 6 | 12486001 | ||
| Pubmed | 3.68e-10 | 7 | 248 | 5 | 11146551 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABR MYO10 PFAS ABCA7 BAP1 PSME4 SBF1 SSH1 PTPRS CHPF CPVL DYNC1H1 PRRC2B ANKRD16 UNC13B FLNC FRAS1 SZT2 AOC2 HECTD4 RAPGEF1 LRRK1 FAM83H KMT2D IGF2R POMGNT2 CSPG4 PDCD11 PC | 1.86e-09 | 1105 | 248 | 29 | 35748872 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.18e-09 | 9 | 248 | 5 | 11953448 | |
| Pubmed | 2.52e-09 | 4 | 248 | 4 | 18400243 | ||
| Pubmed | 8.39e-09 | 22 | 248 | 6 | 15103018 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN2A1 MR1 LGR4 PSMD2 GALNT7 LRP1B ABCA7 NEK9 ITFG1 NRP1 PTPRJ PTPRS MANEAL CHPF CPVL UBE2J1 COL5A1 FAT4 FRAS1 MAN2B2 COPA PDIA3 IGF2R POMGNT2 ERGIC3 TENM3 CSPG4 LRP1 CERCAM | 1.18e-08 | 1201 | 248 | 29 | 35696571 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | AOC1 MAN2A1 GAS6 GALNT7 ITFG1 PTPRJ PTPRS ALDOA CPVL DYNC1H1 HSP90AB3P MPST NID2 MGAM FAT4 MAN2B2 CUBN SEC14L3 IGF2R CSPG4 CNDP2 SMS RTN4RL2 SEC14L2 LRRC15 MASP2 SORD | 1.59e-08 | 1070 | 248 | 27 | 23533145 |
| Pubmed | 8.69e-08 | 7 | 248 | 4 | 36681692 | ||
| Pubmed | 1.02e-07 | 17 | 248 | 5 | 17360745 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO10 WDR18 PSMD2 PFAS STRIP2 BAP1 TUBA1A TSC22D4 ALDOA PRRC2B CA2 UNC13B MPST FLNC IPO7 COPA DYNC2H1 POLA1 OGDH FEM1B IGF2R KCTD3 LRP1 LRRC15 | 2.84e-07 | 1005 | 248 | 24 | 19615732 |
| Pubmed | 3.18e-07 | 164 | 248 | 10 | 32409323 | ||
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 11163133 | ||
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 32154672 | ||
| Pubmed | 3.58e-07 | 3 | 248 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 3.58e-07 | 3 | 248 | 3 | 9722999 | |
| Pubmed | 3.92e-07 | 94 | 248 | 8 | 36584595 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDGFRB MAT2A PSMD2 PFAS ADAR NEK9 DHX9 TUBA1B CDC40 EIF2B5 ALDOA DYNC1H1 CA2 MGAM2 IPO8 IPO7 COPA DYNC2H1 POLA1 TUBA1C OGDH PDIA3 IGF2R UBA6 MTR PDCD11 HSD17B10 PC TOP2B | 4.36e-07 | 1425 | 248 | 29 | 30948266 |
| Pubmed | MAT2A ADAR ITFG1 DHX9 TUBA1B PTPRJ TUBA1A PTPRS CHPF CPVL MAN2B2 IPO7 COPA TUBA1C IGF2R POMGNT2 LRP1 CERCAM | 5.18e-07 | 613 | 248 | 18 | 22268729 | |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 5.24e-07 | 42 | 248 | 6 | 14760703 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 8.01e-07 | 11 | 248 | 4 | 38303699 | |
| Pubmed | 9.03e-07 | 142 | 248 | 9 | 30809309 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | TUBA3E TUBA8 TUBA4A TUBA3C DHX9 TUBA1B TUBA1A ALDOA DYNC1H1 HSP90AB3P IPO7 TUBA1C | 1.26e-06 | 288 | 248 | 12 | 31501420 |
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 32492698 | ||
| Pubmed | 1.43e-06 | 4 | 248 | 3 | 36140829 | ||
| Pubmed | 1.70e-06 | 51 | 248 | 6 | 16919471 | ||
| Pubmed | ABR WDR81 WDR18 NEK9 ADD1 SBF1 SSH1 UBE3A PTPRS DYNC1H1 PRRC2B CACNA1A HECTD4 DGKZ SORBS1 IGF2R FAM171A2 LRP1 UBA6 FRMPD3 TNR LRRC15 | 1.88e-06 | 963 | 248 | 22 | 28671696 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.95e-06 | 200 | 248 | 10 | 35546148 | |
| Pubmed | TUBA8 ADAR TUBA4A DHX9 TUBA1B TUBA1A DYNC1H1 IPO7 TUBA1C PDCD11 | 2.54e-06 | 206 | 248 | 10 | 22174317 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ABR PSMD2 SQOR NRP1 PTPRS FLNC COPA TENT4A TUBA1C SMURF1 BIRC2 MTR | 2.98e-06 | 313 | 248 | 12 | 38270169 |
| Pubmed | A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk. | 3.24e-06 | 15 | 248 | 4 | 20615890 | |
| Pubmed | Subtypes of medulloblastoma have distinct developmental origins. | 3.31e-06 | 57 | 248 | 6 | 21150899 | |
| Pubmed | 3.54e-06 | 5 | 248 | 3 | 24920589 | ||
| Pubmed | 3.89e-06 | 90 | 248 | 7 | 15033168 | ||
| Pubmed | MAT2A WDR18 PSMD2 ADAR NEK9 ADD1 DHX9 ALDOA DYNC1H1 IPO8 IPO7 COPA POLA1 FAM83H PDCD11 HSD17B10 TOP2B | 3.97e-06 | 638 | 248 | 17 | 33239621 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | DHX9 TUBA1B TUBA1A CPVL NID2 FRAS1 TUBA1C OGDH LRP1 HSD17B10 | 4.38e-06 | 219 | 248 | 10 | 31353912 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | PSMD2 ADAR TUBA4A DHX9 DYNC1H1 IPO7 COPA TUBA1C PDCD11 TOP2B | 4.75e-06 | 221 | 248 | 10 | 29991511 |
| Pubmed | SMG1 UBE3A GORASP1 CHPF DYNC1H1 NID2 FLNC SMURF1 LMO4 RFX1 ST6GALNAC2 KMT2D TENM3 CSPG4 LRP1 UBA6 | 6.29e-06 | 591 | 248 | 16 | 15231748 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | WDR81 PSMD2 DHX9 ALDOA DYNC1H1 CA2 FLNC COPA DYNC2H1 TUBA3D TUBA1C OGDH PDIA3 CNDP2 SMS HSD17B10 PC HYDIN SORD | 6.33e-06 | 807 | 248 | 19 | 30575818 |
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 18613978 | ||
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 12090300 | ||
| Pubmed | 7.05e-06 | 6 | 248 | 3 | 10840040 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MAT2A PSMD2 PFAS ALDOA DYNC1H1 CA2 FLNC MAN2B2 IPO7 COPA OGDH CNDP2 | 7.78e-06 | 344 | 248 | 12 | 30333137 |
| Pubmed | MYO10 STRIP2 DYNC1H1 ADGRL3 PRRC2B UNC13B FRAS1 SMURF1 SORBS1 FEM1B TENM3 FAIM2 PLCE1 | 8.39e-06 | 407 | 248 | 13 | 12693553 | |
| Pubmed | 8.99e-06 | 19 | 248 | 4 | 38452762 | ||
| Pubmed | WDR18 PSMD2 ADAR DHX9 ALDOA DYNC1H1 FLNC IPO7 COPA PDIA3 PDCD11 HSD17B10 PC TOP2B | 1.16e-05 | 484 | 248 | 14 | 31995728 | |
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | TUBA8 NEK9 HMCN2 CDC40 PLA1A MICB DYNC1H1 CA2 SMURF1 CHST1 PDIA3 PCK1 | 1.26e-05 | 361 | 248 | 12 | 18976975 |
| Pubmed | 1.45e-05 | 152 | 248 | 8 | 34299191 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MAN2A1 ADGRV1 PTER PTPRJ TUBA1A ALDOA CPVL DYNC1H1 CA2 MPST MXRA5 DYNC2H1 SMURF1 CUBN IGF2R SLC22A2 CNDP2 PCK1 LRRC15 MASP2 SORD | 1.47e-05 | 1016 | 248 | 21 | 19056867 |
| Pubmed | SMG1 PARD6G PTER UBE3A CPVL PRRC2B FAT4 SATB2 MXRA5 IPO7 DYNC2H1 TNC SMARCAL1 RFX1 KMT2D DNAH11 | 1.62e-05 | 638 | 248 | 16 | 31182584 | |
| Pubmed | ADAR SQOR ITFG1 PTPRM PRRC2B UNC13B CACNA1D COL5A1 GLIS3 FICD IGF2R TENM3 | 1.65e-05 | 371 | 248 | 12 | 15747579 | |
| Pubmed | PSMD2 DHX9 TUBA1B ALDOA DYNC1H1 FLNC COPA PDIA3 IGF2R HSD17B10 PC | 1.69e-05 | 312 | 248 | 11 | 37120454 | |
| Pubmed | 1.78e-05 | 76 | 248 | 6 | 27542412 | ||
| Pubmed | Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha. | 1.95e-05 | 8 | 248 | 3 | 19158324 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 1.95e-05 | 8 | 248 | 3 | 21165971 | |
| Pubmed | MAT2A TUBA3E PSMD2 TUBA4A TUBA3C DHX9 TUBA1B TUBA1A UBE3A DYNC1H1 IPO8 IPO7 TUBA1C OGDH PDIA3 IGF2R CNDP2 HSD17B10 SORD | 2.04e-05 | 878 | 248 | 19 | 37223481 | |
| Pubmed | PSMD2 TUBA4A TUBA1B PSME4 TUBA1A DYNC1H1 COPA DYNC2H1 TUBA1C PDIA3 TENM3 | 2.26e-05 | 322 | 248 | 11 | 26514267 | |
| Pubmed | 2.36e-05 | 212 | 248 | 9 | 23463506 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 2.57e-05 | 81 | 248 | 6 | 20697350 | |
| Pubmed | Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice. | 2.92e-05 | 9 | 248 | 3 | 15579434 | |
| Pubmed | 2.92e-05 | 9 | 248 | 3 | 19103752 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 2.92e-05 | 9 | 248 | 3 | 10772929 | |
| Pubmed | 3.25e-05 | 276 | 248 | 10 | 28319085 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.61e-05 | 86 | 248 | 6 | 28327460 | |
| Pubmed | PSMD2 TUBA4A ADD1 DHX9 SBF1 TUBA1A PTPRS TSC22D4 ALDOA DYNC1H1 PRRC2B CA2 CACNA1A FLNC COPA TNC TUBA1C SMURF1 DGKZ SORBS1 OGDH PDIA3 PC TNR DNAH11 | 3.77e-05 | 1431 | 248 | 25 | 37142655 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 3.78e-05 | 281 | 248 | 10 | 30455355 | |
| Pubmed | Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. | 3.89e-05 | 27 | 248 | 4 | 16800626 | |
| Pubmed | 4.14e-05 | 10 | 248 | 3 | 38713721 | ||
| Pubmed | Distinct Modes of Presynaptic Inhibition of Cutaneous Afferents and Their Functions in Behavior. | 4.14e-05 | 10 | 248 | 3 | 30826183 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 4.14e-05 | 10 | 248 | 3 | 15345741 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 4.21e-05 | 54 | 248 | 5 | 21525035 | |
| Pubmed | ANO9 MAT2A WDR18 TUBA3E DHX9 TUBA1B TUBA1A ALDOA UNC13B FLNC POLA1 TUBA1C | 4.47e-05 | 411 | 248 | 12 | 36652389 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MAN2A1 PDGFRB SIRPB2 GALNT7 ADAR SQOR NRP1 TUBA1B SBF1 AEBP1 TBC1D22A ALDOA MPST NID2 FLNC MAN2B2 COPA RFX1 OGDH PDIA3 IGF2R ERGIC3 CSPG4 LRP1 CERCAM | 4.71e-05 | 1451 | 248 | 25 | 30550785 |
| Pubmed | PSMD2 PFAS NDRG2 TUBA4A ADD1 DHX9 ALDOA DYNC1H1 CA2 TUBA1C OGDH PDIA3 GUCY2D CNDP2 | 4.87e-05 | 552 | 248 | 14 | 36293380 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MAT2A PSMD2 PFAS NEK9 TUBA4A DHX9 PSME4 TUBA1A UBE3A ALDOA DYNC1H1 FLNC IPO7 COPA POLA1 TUBA1C PDIA3 PANK4 UBA6 MTR CNDP2 MTRR SMS HSD17B10 SORD | 4.92e-05 | 1455 | 248 | 25 | 22863883 |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 4.94e-05 | 351 | 248 | 11 | 20453000 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 5.06e-05 | 2 | 248 | 2 | 15963947 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 37531512 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 23425389 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 28559284 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 35715601 | ||
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 21092627 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 5.06e-05 | 2 | 248 | 2 | 24268707 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 17611986 | ||
| Pubmed | Human methionine synthase reductase is a molecular chaperone for human methionine synthase. | 5.06e-05 | 2 | 248 | 2 | 16769880 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 5.06e-05 | 2 | 248 | 2 | 16440056 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 33548224 | ||
| Pubmed | Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. | 5.06e-05 | 2 | 248 | 2 | 24516133 | |
| Pubmed | 5.06e-05 | 2 | 248 | 2 | 35428458 | ||
| Interaction | TCP11L2 interactions | 3.62e-09 | 21 | 245 | 7 | int:TCP11L2 | |
| Interaction | PLAUR interactions | MAN2A1 PDGFRB LRP1B TUBA4A TUBA1A UBE3A XRCC3 IGF2R POMGNT2 LRP1 CERCAM TOP2B | 9.84e-08 | 135 | 245 | 12 | int:PLAUR |
| Interaction | CEACAM8 interactions | MAN2A1 ADGRV1 GALNT7 TUBA4A PTPRS MANEAL FAT4 FRAS1 TUBA1C TENM3 CERCAM | 2.28e-07 | 119 | 245 | 11 | int:CEACAM8 |
| Interaction | SCGB2A2 interactions | CTSF MAN2A1 BCHE GALNT7 TUBA4A TUBA1A PTPRS MANEAL CHPF TUBA1C XRCC3 POMGNT2 TENM3 CERCAM | 6.37e-07 | 223 | 245 | 14 | int:SCGB2A2 |
| Interaction | LOC254896 interactions | 7.99e-07 | 43 | 245 | 7 | int:LOC254896 | |
| Interaction | DNASE2B interactions | 9.41e-07 | 44 | 245 | 7 | int:DNASE2B | |
| Interaction | BAGE2 interactions | 2.10e-06 | 70 | 245 | 8 | int:BAGE2 | |
| Interaction | LLCFC1 interactions | 2.28e-06 | 121 | 245 | 10 | int:LLCFC1 | |
| Interaction | GRM7 interactions | 2.58e-06 | 19 | 245 | 5 | int:GRM7 | |
| Interaction | NXPH3 interactions | 6.39e-06 | 58 | 245 | 7 | int:NXPH3 | |
| Interaction | CCT2 interactions | MAT2A RPS6KB2 WDR81 PEX7 TUBA3E PSMD2 PTER TUBA4A TUBA3C FBXL6 BAP1 ITFG1 TUBA1B CDC40 TUBA1A MINDY4 TUBA1C SMURF1 LRRK1 CNDP2 CERCAM HSD17B10 PCK1 | 7.30e-06 | 666 | 245 | 23 | int:CCT2 |
| Interaction | PSG8 interactions | 9.56e-06 | 41 | 245 | 6 | int:PSG8 | |
| Interaction | CLU interactions | PDGFRB LRP1B COMMD1 UBE3A PTPRS MICB TSC22D4 FAT4 TNC RET PDIA3 TENM3 LRP1 | 1.01e-05 | 245 | 245 | 13 | int:CLU |
| Interaction | LY86 interactions | CTSF GAS6 MR1 ADAR TUBA1A NID2 MAN2B2 TUBA1C POMGNT2 CSPG4 PANK4 CERCAM | 1.48e-05 | 217 | 245 | 12 | int:LY86 |
| Interaction | IFNE interactions | 1.65e-05 | 27 | 245 | 5 | int:IFNE | |
| Interaction | LCN6 interactions | 1.68e-05 | 67 | 245 | 7 | int:LCN6 | |
| Interaction | LTA interactions | 1.99e-05 | 28 | 245 | 5 | int:LTA | |
| Interaction | FBXO6 interactions | MAT2A BCHE ADAR ITFG1 DHX9 TUBA1B PTPRJ TUBA1A PTPRS CHPF CPVL FRAS1 MAN2B2 IPO7 COPA TNC TUBA1C IGF2R POMGNT2 ERGIC3 CSPG4 LRP1 CERCAM | 2.36e-05 | 717 | 245 | 23 | int:FBXO6 |
| Interaction | CX3CL1 interactions | 2.47e-05 | 71 | 245 | 7 | int:CX3CL1 | |
| Interaction | NMS interactions | 2.83e-05 | 30 | 245 | 5 | int:NMS | |
| Interaction | TUBB2B interactions | TUBA3E TUBA4A BAP1 ITFG1 TUBA1B TUBA1A UBE3A MICB CACNA1A TUBA1C LRP1 | 4.43e-05 | 205 | 245 | 11 | int:TUBB2B |
| Interaction | EML1 interactions | 4.58e-05 | 33 | 245 | 5 | int:EML1 | |
| Interaction | EDN3 interactions | 5.26e-05 | 108 | 245 | 8 | int:EDN3 | |
| Interaction | TPSB2 interactions | 5.70e-05 | 18 | 245 | 4 | int:TPSB2 | |
| Interaction | LINC01554 interactions | 6.15e-05 | 142 | 245 | 9 | int:LINC01554 | |
| Interaction | BACE2 interactions | 6.31e-05 | 82 | 245 | 7 | int:BACE2 | |
| Interaction | SIAE interactions | 6.82e-05 | 83 | 245 | 7 | int:SIAE | |
| Interaction | MTRR interactions | 7.16e-05 | 19 | 245 | 4 | int:MTRR | |
| Interaction | NSUN5P1 interactions | 7.98e-05 | 59 | 245 | 6 | int:NSUN5P1 | |
| Interaction | SMS interactions | 9.86e-05 | 118 | 245 | 8 | int:SMS | |
| Interaction | PDGFB interactions | 9.90e-05 | 88 | 245 | 7 | int:PDGFB | |
| Interaction | INSYN2A interactions | 1.05e-04 | 39 | 245 | 5 | int:INSYN2A | |
| Interaction | NUP210P1 interactions | 1.50e-04 | 42 | 245 | 5 | int:NUP210P1 | |
| Interaction | SNX21 interactions | 1.63e-04 | 67 | 245 | 6 | int:SNX21 | |
| Interaction | MATK interactions | 1.68e-04 | 43 | 245 | 5 | int:MATK | |
| Interaction | LRRIQ1 interactions | 1.68e-04 | 43 | 245 | 5 | int:LRRIQ1 | |
| Interaction | NTN5 interactions | 1.87e-04 | 24 | 245 | 4 | int:NTN5 | |
| Interaction | NCAN interactions | 1.87e-04 | 24 | 245 | 4 | int:NCAN | |
| Interaction | C2CD4B interactions | 1.88e-04 | 44 | 245 | 5 | int:C2CD4B | |
| Cytoband | 3q13.13-q13.2 | 2.95e-05 | 2 | 250 | 2 | 3q13.13-q13.2 | |
| Cytoband | 12q13.12 | 5.48e-05 | 38 | 250 | 4 | 12q13.12 | |
| Cytoband | 15q15.3 | 3.36e-04 | 25 | 250 | 3 | 15q15.3 | |
| GeneFamily | Tubulins | 5.00e-11 | 26 | 163 | 8 | 778 | |
| GeneFamily | Cadherin related | 1.38e-05 | 17 | 163 | 4 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 6.26e-04 | 160 | 163 | 7 | 555 | |
| GeneFamily | Mannosidases alpha class 2 | 7.94e-04 | 5 | 163 | 2 | 1194 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.49e-04 | 21 | 163 | 3 | 813 | |
| GeneFamily | SEC14 family|PRELI domain containing | 1.18e-03 | 6 | 163 | 2 | 1063 | |
| GeneFamily | Adenosine deaminases acting on RNA | 2.18e-03 | 8 | 163 | 2 | 1303 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 6.04e-07 | 33 | 248 | 6 | M7409 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.89e-06 | 196 | 248 | 11 | M3008 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP | MAT2A SQLE PFAS DCDC2B PTER NRP1 SAMD9L CDC40 PLA1A MTRR CD96 | 3.35e-06 | 199 | 248 | 11 | M5599 |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 1.19e-05 | 32 | 248 | 5 | MM657 | |
| Coexpression | NABA_CORE_MATRISOME | GAS6 HMCN2 AEBP1 COL5A1 NID2 FRAS1 MXRA5 TNC EMILIN1 NTN4 OIT3 TNR | 1.35e-05 | 275 | 248 | 12 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.51e-05 | 191 | 248 | 10 | MM17059 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 2.15e-05 | 199 | 248 | 10 | M6443 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.15e-05 | 199 | 248 | 10 | M3197 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | SQOR DHX9 STAB1 TUBA1A ALDOA CPVL MGAM2 MGAM TUBA1C LRRK1 LMO4 BICRAL SORD | 2.54e-05 | 342 | 248 | 13 | M41062 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 3.20e-05 | 64 | 248 | 6 | M2572 | |
| Coexpression | BRIDEAU_IMPRINTED_GENES | 3.50e-05 | 65 | 248 | 6 | M2491 | |
| Coexpression | BRIDEAU_IMPRINTED_GENES | 5.34e-05 | 70 | 248 | 6 | MM954 | |
| Coexpression | NABA_CORE_MATRISOME | GAS6 HMCN2 AEBP1 COL5A1 NID2 FRAS1 TNC EMILIN1 NTN4 OIT3 TNR | 5.76e-05 | 270 | 248 | 11 | MM17057 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | BCHE ADD1 ALMS1 CDC40 UBE3A CACNA1A MAN2B2 IPO8 CUBN RFX1 SLC22A18 CELF2 MTR BICRAL PCK1 | 6.17e-05 | 482 | 248 | 15 | M12144 |
| Coexpression | IKEDA_MIR30_TARGETS_DN | 7.16e-05 | 24 | 248 | 4 | MM932 | |
| Coexpression | IKEDA_MIR30_TARGETS_DN | 7.16e-05 | 24 | 248 | 4 | M2380 | |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN | 7.42e-05 | 186 | 248 | 9 | M1993 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | MYO10 ADGRV1 SIX4 ITGA9 NDRG2 STRIP2 GJD3 UNC13B COL5A1 NID2 FAT4 SATB2 CWH43 HTR7 TUBA1C GLIS3 LRRK1 RET ST6GALNAC2 NTN4 CDH22 CSPG4 GUCY2D DNAH11 | 9.31e-05 | 1074 | 248 | 24 | M1941 |
| Coexpression | TOMIDA_METASTASIS_UP | 9.93e-05 | 26 | 248 | 4 | M17830 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CTSF PDGFRB NRP1 GBP4 AEBP1 PTPRM PTPRS ADGRL3 COL5A1 MXRA5 DYNC2H1 TEK EMILIN1 CSPG4 LRP1 | 1.04e-04 | 505 | 248 | 15 | M39167 |
| Coexpression | GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP | 1.24e-04 | 199 | 248 | 9 | M4970 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 1.24e-04 | 199 | 248 | 9 | M7420 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.24e-04 | 199 | 248 | 9 | M4444 | |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | 1.27e-04 | 246 | 248 | 10 | M2206 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN | 1.29e-04 | 200 | 248 | 9 | M8572 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 1.29e-04 | 200 | 248 | 9 | M5286 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP | 1.29e-04 | 200 | 248 | 9 | M6686 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP | 1.29e-04 | 200 | 248 | 9 | M5602 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ADGRV1 LRP1B FREM1 DNAH9 ADGRL3 MGAM FAT4 FRAS1 FAT3 ZFHX4 TENM1 HYDIN PLCE1 DNAH11 | 1.69e-13 | 184 | 250 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ADGRV1 LRP1B FREM1 DNAH9 ADGRL3 MGAM FAT4 FRAS1 FAT3 ZFHX4 TENM1 HYDIN PLCE1 DNAH11 | 1.69e-13 | 184 | 250 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 ADGRV1 LRP1B FREM1 DNAH9 ADGRL3 MGAM FAT4 FRAS1 FAT3 ZFHX4 TENM1 HYDIN PLCE1 DNAH11 | 1.69e-13 | 184 | 250 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB MYO10 FREM1 AEBP1 PTPRS CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 LRP1 | 8.48e-10 | 189 | 250 | 12 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 AEBP1 PTPRS CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.14e-09 | 194 | 250 | 12 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 SATB2 TNC FAT3 EMILIN1 ZFHX4 TENM3 CSPG4 CERCAM LRRC15 | 1.62e-09 | 200 | 250 | 12 | 780d47f8eff630020dfae32218de495a7e9dbad6 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 SATB2 TNC FAT3 EMILIN1 ZFHX4 TENM3 CSPG4 CERCAM LRRC15 | 1.62e-09 | 200 | 250 | 12 | 28dd127787a57276253548d1f030814b1af64481 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 LRP1B AEBP1 DNAH9 FRAS1 TAS1R3 FAT3 CUBN RNF17 HYDIN DNAH11 | 3.34e-09 | 169 | 250 | 11 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | IGFN1 MYO10 CDH23 FREM1 NRP1 AEBP1 PTPRS CACNA1D COL5A1 TNC EMILIN1 | 9.61e-09 | 187 | 250 | 11 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 AEBP1 CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.26e-08 | 192 | 250 | 11 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | MYO10 FREM1 NRP1 PTPRS CACNA1D COL5A1 FAT4 FRAS1 TNC FAT3 EMILIN1 | 1.33e-08 | 193 | 250 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 FREM1 NRP1 CACNA1D COL5A1 FAT4 TNC FAT3 GLIS3 LMO4 EMILIN1 | 1.41e-08 | 194 | 250 | 11 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MYO10 PARD6G PTPRS CHPF COL5A1 SATB2 FAT3 AOC2 TENM3 CERCAM LRRC15 | 1.41e-08 | 194 | 250 | 11 | 292ce9021678534c9eedb367b9772a9d976208a8 |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | PDGFRB MYOG NRP1 AEBP1 COL5A1 NID2 MXRA5 EMILIN1 TENM3 CERCAM LRRC15 | 1.41e-08 | 194 | 250 | 11 | 55b97095a7a17a312c616703d291738a0f806339 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 FRAS1 SATB2 MXRA5 TNC FAT3 ZFHX4 TENM3 CERCAM | 1.65e-08 | 197 | 250 | 11 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 FRAS1 SATB2 MXRA5 TNC FAT3 ZFHX4 TENM3 CERCAM | 1.65e-08 | 197 | 250 | 11 | fb50903b87498b400c8e16e6a561b6d9458e5d97 |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | CTSF PDGFRB AEBP1 COL5A1 NID2 MXRA5 DYNC2H1 TNC GLIS3 EMILIN1 CERCAM | 1.74e-08 | 198 | 250 | 11 | e8c0fbf306fae13e97caa294d7c99a564bd97130 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRB ITGA9 ADGRL3 COL5A1 NID2 FAT4 MXRA5 TNC EMILIN1 LRP1 TNR | 1.74e-08 | 198 | 250 | 11 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRB MYO10 FREM1 CACNA1D COL5A1 NID2 DYNC2H1 TNC TENM3 LRP1 LRRC15 | 1.83e-08 | 199 | 250 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | CHPF COL5A1 SATB2 MXRA5 TNC FAT3 EMILIN1 ZFHX4 TENM3 CERCAM LRRC15 | 1.83e-08 | 199 | 250 | 11 | bf138cc692df727e087d140c014149ee5da00d9d |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | CHPF COL5A1 SATB2 MXRA5 TNC FAT3 EMILIN1 ZFHX4 TENM3 CERCAM LRRC15 | 1.83e-08 | 199 | 250 | 11 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | PDGFRB FREM1 AEBP1 PTPRS CACNA1D COL5A1 FAT4 TNC FAT3 EMILIN1 TENM3 | 1.83e-08 | 199 | 250 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CTSF PDGFRB GAS6 AEBP1 TUBA1A CHPF TNC EMILIN1 ZFHX4 TENM3 LRP1 | 1.83e-08 | 199 | 250 | 11 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | PDGFRB MYO10 FREM1 NRP1 MINDY4 CACNA1D COL5A1 NID2 DYNC2H1 TNC LRP1 | 1.93e-08 | 200 | 250 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 AEBP1 SLITRK6 CACNA1D COL5A1 FAT4 MXRA5 EMILIN1 RGN TENM1 | 1.93e-08 | 200 | 250 | 11 | fb53be20392a8309a7393774c774a1b1aec6e676 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 NRP1 CACNA1D COL5A1 FAT4 MXRA5 RGN CELF2 TENM1 LRP1 | 1.93e-08 | 200 | 250 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB MYO10 FREM1 NRP1 PTPRS CACNA1D COL5A1 FRAS1 FAT3 TENM3 LRP1 | 1.93e-08 | 200 | 250 | 11 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 NRP1 AEBP1 COL5A1 FAT4 MXRA5 EMILIN1 RGN LRP1 LRRC15 | 1.93e-08 | 200 | 250 | 11 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 NRP1 AEBP1 PTPRS CACNA1D COL5A1 FAT4 FAT3 TENM3 LRP1 | 1.93e-08 | 200 | 250 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.57e-08 | 170 | 250 | 10 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.05e-08 | 178 | 250 | 10 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PARD6G COL5A1 SATB2 TNC FAT3 PCDHAC1 EMILIN1 BPIFB4 CERCAM LRRC15 | 9.14e-08 | 183 | 250 | 10 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-08 | 184 | 250 | 10 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PDGFRB MYO10 ADGRV1 NDRG2 AEBP1 TSC22D4 NWD1 TNC GLIS3 ZFHX4 | 1.12e-07 | 187 | 250 | 10 | dd1d91f101b837bba513f77defa6e6902b2c0570 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | PDGFRB MYO10 ADGRV1 NDRG2 AEBP1 TSC22D4 NWD1 TNC GLIS3 ZFHX4 | 1.12e-07 | 187 | 250 | 10 | ae90c263f80c36a410150d499e268d198944a3d9 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-07 | 188 | 250 | 10 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.24e-07 | 189 | 250 | 10 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB NDRG2 FREM1 AEBP1 CACNA1D TNC FAT3 GLIS3 EMILIN1 LRP1 | 1.30e-07 | 190 | 250 | 10 | 841cd55861b43578d704418b9bc0af2e8b88323a |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TRPC3 PARD6G ITGA9 STAB1 AEBP1 FLNC FAM171A2 TENM3 SORD PLCE1 | 1.30e-07 | 190 | 250 | 10 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TRPC3 PARD6G ITGA9 STAB1 AEBP1 FLNC FAM171A2 TENM3 SORD PLCE1 | 1.30e-07 | 190 | 250 | 10 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TRPC3 PARD6G ITGA9 STAB1 AEBP1 FLNC FAM171A2 TENM3 SORD PLCE1 | 1.30e-07 | 190 | 250 | 10 | b79ffd05806244a9790cd04c66fb4f92c824e69f |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 AEBP1 CACNA1D TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.36e-07 | 191 | 250 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFRB ITGA9 NRP1 AEBP1 COL5A1 SORBS1 EMILIN1 TENM3 LRP1 FAIM2 | 1.43e-07 | 192 | 250 | 10 | bc84b9ce01b4d826a682842ab8a395dac9b91183 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDGFRB ITGA9 NRP1 AEBP1 COL5A1 SORBS1 EMILIN1 TENM3 LRP1 FAIM2 | 1.43e-07 | 192 | 250 | 10 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 AEBP1 CACNA1D TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.43e-07 | 192 | 250 | 10 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 AEBP1 CACNA1D TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.43e-07 | 192 | 250 | 10 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.43e-07 | 192 | 250 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ADGRV1 DNAH9 NWD1 DYNC2H1 TNC GLIS3 SEC14L3 HYDIN CFAP46 DNAH11 | 1.50e-07 | 193 | 250 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDGFRB FREM1 CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.50e-07 | 193 | 250 | 10 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGFN1 PDGFRB AEBP1 PTPRS ADGRL3 COL5A1 NID2 ZFHX4 CELF2 LRP1 | 1.58e-07 | 194 | 250 | 10 | c49f72441b3557e2c3a9c4239e68c0cf0652814b |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FREM1 PTPRS CACNA1D COL5A1 TNC FAT3 GLIS3 EMILIN1 TENM3 LRP1 | 1.58e-07 | 194 | 250 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | MYO10 PARD6G PTPRS COL5A1 SATB2 FAT3 AOC2 TENM3 CERCAM LRRC15 | 1.58e-07 | 194 | 250 | 10 | 811b382ec3da06a6bda7360abc8b633f96b2019e |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PDGFRB FREM1 CACNA1D COL5A1 FAT4 FAT3 GLIS3 LMO4 EMILIN1 LRP1 | 1.65e-07 | 195 | 250 | 10 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | FREM1 CACNA1D COL5A1 FAT4 FAT3 GLIS3 LMO4 EMILIN1 CELF2 LRP1 | 1.73e-07 | 196 | 250 | 10 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-07 | 196 | 250 | 10 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-07 | 196 | 250 | 10 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 SATB2 TNC FAT3 CHST1 EMILIN1 ZFHX4 TENM3 CERCAM LRRC15 | 1.82e-07 | 197 | 250 | 10 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | PDGFRB MYO10 FREM1 CACNA1D FAT3 GLIS3 LMO4 EMILIN1 CELF2 LRP1 | 1.82e-07 | 197 | 250 | 10 | 31a1852911bda38543916585fda34255fd62a134 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-07 | 198 | 250 | 10 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PARD6G ANO4 COL5A1 SATB2 TNC FAT3 EMILIN1 ZFHX4 CERCAM LRRC15 | 1.90e-07 | 198 | 250 | 10 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PDGFRB FREM1 NRP1 CACNA1D COL5A1 FAT4 TNC FAT3 EMILIN1 TENM3 | 1.90e-07 | 198 | 250 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-07 | 198 | 250 | 10 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-07 | 198 | 250 | 10 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDGFRB CDH23 AEBP1 PTPRS CACNA1D COL5A1 FAT3 EMILIN1 TENM3 LRP1 | 1.90e-07 | 198 | 250 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB COL5A1 SATB2 MXRA5 DYNC2H1 TNC FAT3 EMILIN1 ZFHX4 CERCAM | 1.90e-07 | 198 | 250 | 10 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 198 | 250 | 10 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 SATB2 MXRA5 TNC FAT3 EMILIN1 ZFHX4 CERCAM | 2.00e-07 | 199 | 250 | 10 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PDGFRB MYO10 BCHE FREM1 SLITRK6 CACNA1D COL5A1 DYNC2H1 TNC LRP1 | 2.00e-07 | 199 | 250 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB PARD6G COL5A1 SATB2 MXRA5 TNC FAT3 EMILIN1 ZFHX4 CERCAM | 2.00e-07 | 199 | 250 | 10 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 SATB2 TNC FAT3 EMILIN1 ZFHX4 TENM3 CSPG4 CERCAM LRRC15 | 2.09e-07 | 200 | 250 | 10 | 16a7c398626b6e82b394eb3ef013bda3a788659d |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-07 | 200 | 250 | 10 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-07 | 200 | 250 | 10 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | PDGFRB NDRG2 AEBP1 PTPRS CACNA1D FAT4 FRAS1 TNC FAT3 EMILIN1 | 2.09e-07 | 200 | 250 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | PDGFRB NDRG2 AEBP1 PTPRS CACNA1D FAT4 FRAS1 TNC FAT3 EMILIN1 | 2.09e-07 | 200 | 250 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 NRP1 AEBP1 PTPRS CACNA1D COL5A1 FAT3 TENM3 LRP1 | 2.09e-07 | 200 | 250 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-07 | 200 | 250 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | PDGFRB BCHE AEBP1 PTPRS COL5A1 NID2 FLNC MXRA5 EMILIN1 ZFHX4 | 2.09e-07 | 200 | 250 | 10 | cdaf462b1db29dab61038eeab5ddd3eef3386763 |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-07 | 200 | 250 | 10 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB NRP1 COL5A1 FRAS1 SATB2 MXRA5 TNC EMILIN1 ZFHX4 CSPG4 | 2.09e-07 | 200 | 250 | 10 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PARD6G COL5A1 SATB2 MXRA5 TNC FAT3 ZFHX4 TENM3 CERCAM LRRC15 | 2.09e-07 | 200 | 250 | 10 | 3c898e81444b001835c3f1bbc68183078701b135 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PARD6G COL5A1 SATB2 MXRA5 TNC FAT3 ZFHX4 TENM3 CERCAM LRRC15 | 2.09e-07 | 200 | 250 | 10 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRB FREM1 NRP1 AEBP1 PTPRS CACNA1D COL5A1 FAT3 TENM3 LRP1 | 2.09e-07 | 200 | 250 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | PDGFRB NDRG2 AEBP1 PTPRS CACNA1D FAT4 FRAS1 TNC FAT3 EMILIN1 | 2.09e-07 | 200 | 250 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-07 | 200 | 250 | 10 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 160 | 250 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 160 | 250 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-07 | 162 | 250 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.53e-07 | 162 | 250 | 9 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-07 | 166 | 250 | 9 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-07 | 170 | 250 | 9 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.84e-07 | 172 | 250 | 9 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-07 | 175 | 250 | 9 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.75e-07 | 175 | 250 | 9 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-07 | 177 | 250 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-07 | 178 | 250 | 9 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.16e-07 | 179 | 250 | 9 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-07 | 180 | 250 | 9 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.37e-07 | 182 | 250 | 9 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.37e-07 | 182 | 250 | 9 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.37e-07 | 182 | 250 | 9 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| Drug | Epothilone D | 1.25e-09 | 12 | 244 | 6 | DB01873 | |
| Drug | Epothilone B | 1.25e-09 | 12 | 244 | 6 | DB03010 | |
| Drug | mpMap | 2.13e-07 | 25 | 244 | 6 | CID000100806 | |
| Drug | NSC332029 | 2.74e-07 | 26 | 244 | 6 | CID000100073 | |
| Drug | glycerol | TUBA3E BCHE PFAS ADGRV1 TUBA8 ADARB2 TUBA4A ITFG1 PLA1A TUBA1A DGAT2 NR0B1 ALDOA CA2 DAGLB LIAS MGAM POLA1 TUBA1C OGDH OGG1 IGF2R HSD17B10 PC PCK1 MASP2 SORD | 3.10e-07 | 829 | 244 | 27 | CID000000753 |
| Drug | 2-(N-morpholino)ethanesulfonic acid | 3.61e-07 | 86 | 244 | 9 | CID000078165 | |
| Drug | A805480 | 4.07e-07 | 44 | 244 | 7 | CID000620368 | |
| Drug | PIPES | 4.09e-07 | 64 | 244 | 8 | CID000079723 | |
| Drug | bp U | 5.50e-07 | 29 | 244 | 6 | CID000368697 | |
| Drug | azatoxin | 6.82e-07 | 30 | 244 | 6 | CID000125383 | |
| Drug | thiocolchicine | 6.82e-07 | 30 | 244 | 6 | CID000017648 | |
| Drug | magnesium | MAT2A TRPC3 SQLE TUBA3E BCHE ADGRV1 TUBA8 ITGA9 NDRG2 TUBA4A PLA1A TUBA1A DGAT2 PIK3CB TBC1D22A MMP10 DNAH9 DYNC1H1 CA2 MGAM MAN2B2 TNC TMEM54 POLA1 TUBA1C DGKZ XRCC3 OGDH OGG1 TH MTR PC PCK1 TOP2B DNAH11 | 7.49e-07 | 1325 | 244 | 35 | CID000000888 |
| Drug | vinylene carbonate | 8.71e-07 | 8 | 244 | 4 | CID000013385 | |
| Drug | magnesium sulfate | 1.32e-06 | 52 | 244 | 7 | CID000024083 | |
| Drug | N5,N10-methylene tetrahydrofolic acid | 1.41e-06 | 75 | 244 | 8 | CID000000884 | |
| Drug | imipramine | PLCXD2 TUBA3E BCHE TUBA8 TUBA4A NRP1 TUBA1A HTR7 TUBA1C AOC2 TH MTRR PLCE1 | 1.67e-06 | 235 | 244 | 13 | CID000003696 |
| Drug | bromocolchicine | 2.40e-06 | 21 | 244 | 5 | CID000161518 | |
| Drug | colchifoline | 2.40e-06 | 21 | 244 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 2.40e-06 | 21 | 244 | 5 | CID000164454 | |
| Drug | SRI-3072 | 2.40e-06 | 21 | 244 | 5 | CID000493469 | |
| Drug | colchiceine | 2.95e-06 | 38 | 244 | 6 | CID000010156 | |
| Drug | 3,4,5-trimethoxyacetophenone | 3.08e-06 | 22 | 244 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 3.08e-06 | 22 | 244 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 3.08e-06 | 22 | 244 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 3.08e-06 | 22 | 244 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 3.08e-06 | 22 | 244 | 5 | CID000023759 | |
| Drug | NSC-339672 | 3.08e-06 | 22 | 244 | 5 | CID000433930 | |
| Drug | Dolastatin 10 | 3.46e-06 | 39 | 244 | 6 | CID000100208 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 3.90e-06 | 23 | 244 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 3.90e-06 | 23 | 244 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 3.90e-06 | 23 | 244 | 5 | CID000125548 | |
| Drug | NSC-373301 | 3.90e-06 | 23 | 244 | 5 | CID000341375 | |
| Drug | NSC355636 | 3.90e-06 | 23 | 244 | 5 | CID000100176 | |
| Drug | IKP104 | 3.90e-06 | 23 | 244 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 3.90e-06 | 23 | 244 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 3.90e-06 | 23 | 244 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 3.90e-06 | 23 | 244 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 3.90e-06 | 23 | 244 | 5 | CID000097865 | |
| Drug | B-Ms | 3.92e-06 | 114 | 244 | 9 | CID000445091 | |
| Drug | epo906 | 3.92e-06 | 114 | 244 | 9 | CID000388945 | |
| Drug | plumbagin | 3.97e-06 | 61 | 244 | 7 | CID000010205 | |
| Drug | amoebal | 4.68e-06 | 41 | 244 | 6 | CID000001985 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 4.82e-06 | 4 | 244 | 3 | DB07574 | |
| Drug | parbendazole | 4.88e-06 | 24 | 244 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 4.88e-06 | 24 | 244 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 4.88e-06 | 24 | 244 | 5 | CID000330401 | |
| Drug | NABV | 4.88e-06 | 24 | 244 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 4.88e-06 | 24 | 244 | 5 | CID000163705 | |
| Drug | moscatilin | 4.88e-06 | 24 | 244 | 5 | CID000176096 | |
| Drug | NSC-36768 | 4.88e-06 | 24 | 244 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 4.88e-06 | 24 | 244 | 5 | CID000014995 | |
| Drug | colchicide | 4.88e-06 | 24 | 244 | 5 | CID000120712 | |
| Drug | AC1L1IZ2 | MYO10 MAT2A TUBA3E PSMD2 TUBA8 TUBA4A TUBA1A DNAH9 DYNC1H1 MGAM TUBA1C GUCY2D CNDP2 TOP2B | 5.66e-06 | 304 | 244 | 14 | CID000004795 |
| Drug | AC1Q6P06 | 6.05e-06 | 25 | 244 | 5 | CID000160263 | |
| Drug | allocolchicine | 6.05e-06 | 25 | 244 | 5 | CID000196989 | |
| Drug | 1069C85 | 6.05e-06 | 25 | 244 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 6.05e-06 | 25 | 244 | 5 | CID006438440 | |
| Drug | MDL 27048 | 6.05e-06 | 25 | 244 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 6.05e-06 | 25 | 244 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 6.05e-06 | 25 | 244 | 5 | CID000043264 | |
| Drug | CA1P | 6.05e-06 | 25 | 244 | 5 | CID006918545 | |
| Drug | peloruside A | 6.05e-06 | 25 | 244 | 5 | CID006918506 | |
| Drug | NSC142227 | 6.05e-06 | 25 | 244 | 5 | CID000073427 | |
| Drug | procaine | GABRQ TUBA3E BCHE TUBA8 TUBA4A TUBA1A CACNA1A CACNA1D LIAS TUBA1C | 6.25e-06 | 153 | 244 | 10 | CID000004914 |
| Drug | ABT-751 | 7.15e-06 | 44 | 244 | 6 | CID003035714 | |
| Drug | NSC527981 | 7.43e-06 | 26 | 244 | 5 | CID000352796 | |
| Drug | indibulin | 7.43e-06 | 26 | 244 | 5 | CID000002929 | |
| Drug | pironetin | 7.43e-06 | 26 | 244 | 5 | CID006438891 | |
| Drug | isaxonine | 7.43e-06 | 26 | 244 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 9.03e-06 | 27 | 244 | 5 | CID000004862 | |
| Drug | dinitroanilines | 9.03e-06 | 27 | 244 | 5 | CID000136400 | |
| Drug | NSC292222 | 9.03e-06 | 27 | 244 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 9.03e-06 | 27 | 244 | 5 | CID000178028 | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; PC3; HT_HG-U133A | GAS6 NEK9 PARD6A PIK3CB C1orf105 TSC22D4 PTBP3 COPA TNC SMURF1 LRRK1 | 9.72e-06 | 197 | 244 | 11 | 5114_DN |
| Drug | ammonia | AOC1 GLS2 MAT2A TUBA3E BCHE TUBA8 ADAR TUBA4A TUBA1A CA2 LIAS MGAM TMEM54 TUBA1C AOC2 OGDH PC SEC14L2 | 1.06e-05 | 509 | 244 | 18 | CID000000222 |
| Drug | NSC 370147 | 1.09e-05 | 28 | 244 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.09e-05 | 28 | 244 | 5 | CID000118078 | |
| Drug | oxibendazole | 1.31e-05 | 29 | 244 | 5 | CID000004622 | |
| Drug | Aids106696 | 1.31e-05 | 29 | 244 | 5 | CID006475933 | |
| Drug | ddGDP | 1.31e-05 | 29 | 244 | 5 | CID000134739 | |
| Drug | evodiamine | 1.33e-05 | 73 | 244 | 7 | CID000151289 | |
| Drug | NSC654663 | 1.35e-05 | 49 | 244 | 6 | CID000375252 | |
| Drug | 3-aminopropyl | 1.35e-05 | 49 | 244 | 6 | CID000007852 | |
| Drug | monomethyl phthalate | PDGFRB MAT2A TRPC3 LGR4 TUBA4A DHX9 STAB1 COMMD1 GBP4 ALDOA NID2 MGAM RET CUBN PDIA3 NTN4 RGN IGF2R UBA6 CNDP2 HSD17B10 PC PCK1 TOP2B SEC14L2 PLCE1 | 1.39e-05 | 957 | 244 | 26 | ctd:C517284 |
| Drug | sodium bicarbonate | 1.46e-05 | 74 | 244 | 7 | CID000010340 | |
| Drug | Taxane | 1.54e-05 | 103 | 244 | 8 | CID000108169 | |
| Drug | manganese | ERBB4 MR1 TUBA3E TUBA8 ITGA9 NEK9 TUBA4A TUBA1B TUBA1A CHPF CA2 CACNA1A CACNA1D MGAM TMEM54 POLA1 TUBA1C RGN GUCY2D CNDP2 ADAM2 PC PCK1 | 1.55e-05 | 791 | 244 | 23 | CID000023930 |
| Drug | AC1NBBHE | 1.55e-05 | 30 | 244 | 5 | CID004490620 | |
| Drug | eleutherobin | 1.55e-05 | 30 | 244 | 5 | CID006918335 | |
| Drug | NSC617668 | 1.55e-05 | 30 | 244 | 5 | CID000357989 | |
| Drug | citostal | 1.55e-05 | 30 | 244 | 5 | CID000018991 | |
| Drug | TK-B | 1.71e-05 | 51 | 244 | 6 | CID000009074 | |
| Drug | NSC609395 | 1.84e-05 | 31 | 244 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 1.84e-05 | 31 | 244 | 5 | CID000100524 | |
| Drug | AC7700 | 1.84e-05 | 31 | 244 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 1.84e-05 | 31 | 244 | 5 | CID000032851 | |
| Drug | tropone | 1.84e-05 | 31 | 244 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 1.84e-05 | 31 | 244 | 5 | CID000122777 | |
| Drug | NSC332598 | 1.84e-05 | 31 | 244 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.84e-05 | 31 | 244 | 5 | CID000023678 | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.08e-17 | 8 | 246 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.08e-17 | 8 | 246 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.08e-17 | 8 | 246 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DYNC1H1 TUBA3D TUBA1C | 6.91e-13 | 27 | 246 | 9 | DOID:0050453 (implicated_via_orthology) |
| Disease | Malignant neoplasm of breast | ERBB4 ABHD12B RPS6KB2 BCHE SIX4 ITGA9 ADAR BAP1 PIK3CB TSC22D4 MMP10 ALDOA DNAH9 NID2 DYNC2H1 SMARCAL1 BIRC2 SORBS1 CUBN XRCC3 TEK MAMDC4 SLC22A18 KMT2D TENM1 MTR | 1.28e-06 | 1074 | 246 | 26 | C0006142 |
| Disease | whole-brain volume | 5.65e-06 | 5 | 246 | 3 | EFO_0005089 | |
| Disease | urate measurement | ERBB4 GLS2 LGR4 ADGRV1 STAB1 DGAT2 PIP5KL1 MINDY4 PRRC2B HSP90AB3P HECTD4 GLIS3 CHST1 CUBN XRCC3 SEC14L3 NTN4 CSPG4 LRP1 PC FAIM2 SORD | 6.88e-06 | 895 | 246 | 22 | EFO_0004531 |
| Disease | melanoma | 8.34e-06 | 248 | 246 | 11 | C0025202 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.92e-05 | 105 | 246 | 7 | DOID:9352 (implicated_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 3.11e-05 | 8 | 246 | 3 | C0266294 | |
| Disease | Male sterility | 4.94e-05 | 48 | 246 | 5 | C0917731 | |
| Disease | Male infertility | 4.94e-05 | 48 | 246 | 5 | C0021364 | |
| Disease | Subfertility, Male | 4.94e-05 | 48 | 246 | 5 | C0848676 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 6.92e-05 | 2 | 246 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | delivery measurement, spontaneous preterm birth | 6.92e-05 | 2 | 246 | 2 | EFO_0006917, EFO_0006922 | |
| Disease | epilepsy (implicated_via_orthology) | 7.12e-05 | 163 | 246 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | ERBB4 TRPC3 BCHE TUBA8 ITGA9 STAB1 MMP10 CACNA1A CACNA1D TH MTR SMS PC | 2.04e-04 | 477 | 246 | 13 | C0005586 |
| Disease | Severe Dengue | 2.07e-04 | 3 | 246 | 2 | C0019100 | |
| Disease | Dengue Shock Syndrome | 2.07e-04 | 3 | 246 | 2 | C0376300 | |
| Disease | Neural tube defects, folate-sensitive | 4.11e-04 | 4 | 246 | 2 | cv:C1866558 | |
| Disease | ADP-ribosylation factor-like protein 11 measurement | 4.11e-04 | 4 | 246 | 2 | EFO_0801355 | |
| Disease | Neural tube defect, folate-sensitive | 4.11e-04 | 4 | 246 | 2 | C1866558 | |
| Disease | NEURAL TUBE DEFECTS, FOLATE-SENSITIVE | 4.11e-04 | 4 | 246 | 2 | 601634 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 4.11e-04 | 4 | 246 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 4.11e-04 | 4 | 246 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | coronary artery disease | ERBB4 GLS2 MAT2A ADARB2 NEK9 NRP1 COMMD1 PTPRJ MICB ADGRL3 DAGLB FAT4 TENT4A DYNC2H1 HECTD4 TEK IGF2R OIT3 CRYGN SLC22A2 LRP1 PLCE1 | 4.58e-04 | 1194 | 246 | 22 | EFO_0001645 |
| Disease | Breast Carcinoma | ERBB4 RPS6KB2 BCHE ADAR BAP1 PIK3CB ALDOA DYNC2H1 BIRC2 XRCC3 SLC22A18 KMT2D MTR | 6.37e-04 | 538 | 246 | 13 | C0678222 |
| Disease | Hydrophthalmos | 6.81e-04 | 5 | 246 | 2 | C0020302 | |
| Disease | heart disease (is_implicated_in) | 6.81e-04 | 5 | 246 | 2 | DOID:114 (is_implicated_in) | |
| Disease | Congenital absence of kidneys syndrome | 6.81e-04 | 5 | 246 | 2 | C1609433 | |
| Disease | Dystonia | 7.78e-04 | 86 | 246 | 5 | C0013421 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 8.63e-04 | 88 | 246 | 5 | EFO_0803332 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 8.96e-04 | 23 | 246 | 3 | C1708353 | |
| Disease | spina bifida (is_implicated_in) | 1.02e-03 | 6 | 246 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 1.02e-03 | 6 | 246 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | clubfoot (implicated_via_orthology) | 1.02e-03 | 6 | 246 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | small integral membrane protein 9 measurement | 1.02e-03 | 6 | 246 | 2 | EFO_0802075 | |
| Disease | Squamous cell carcinoma of esophagus | 1.22e-03 | 95 | 246 | 5 | C0279626 | |
| Disease | migraine disorder, pulse pressure measurement | 1.29e-03 | 26 | 246 | 3 | EFO_0005763, MONDO_0005277 | |
| Disease | DNA methylation | LRP1B FREM1 ALMS1 PTPRM PTPRS FAT4 WDR27 MON1B TENM3 CELF2 MROH2B TNR PLCE1 DNAH11 | 1.32e-03 | 656 | 246 | 14 | GO_0006306 |
| Disease | Dengue Hemorrhagic Fever | 1.41e-03 | 7 | 246 | 2 | EFO_0004227 | |
| Disease | acisoga measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0800068 | |
| Disease | BPI fold-containing family B member 1 measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0801429 | |
| Disease | pheochromocytoma (is_implicated_in) | 1.41e-03 | 7 | 246 | 2 | DOID:0050771 (is_implicated_in) | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.50e-03 | 59 | 246 | 4 | EFO_0009658, GO_0009410 | |
| Disease | Mental deterioration | 1.78e-03 | 29 | 246 | 3 | HP_0001268 | |
| Disease | 1,5 anhydroglucitol measurement | 1.78e-03 | 29 | 246 | 3 | EFO_0008009 | |
| Disease | tyrosine measurement | 1.82e-03 | 104 | 246 | 5 | EFO_0005058 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 1.88e-03 | 8 | 246 | 2 | DOID:5520 (is_marker_for) | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 1.88e-03 | 8 | 246 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | Congenital Hydrocephalus | 1.88e-03 | 8 | 246 | 2 | C0020256 | |
| Disease | peroxisomal biogenesis disorder (is_implicated_in) | 1.88e-03 | 8 | 246 | 2 | DOID:0080377 (is_implicated_in) | |
| Disease | uric acid measurement | ERBB4 ADGRV1 MINDY4 PRRC2B FAT4 FRAS1 DYNC2H1 FAT3 HECTD4 CUBN NTN4 GUCY2D FAIM2 | 1.96e-03 | 610 | 246 | 13 | EFO_0004761 |
| Disease | Huntington disease, disease progression measurement | 1.97e-03 | 30 | 246 | 3 | EFO_0008336, MONDO_0007739 | |
| Disease | Disorder of eye | 2.09e-03 | 212 | 246 | 7 | C0015397 | |
| Disease | histidine measurement | 2.27e-03 | 66 | 246 | 4 | EFO_0009769 | |
| Disease | Ciliopathies | 2.33e-03 | 110 | 246 | 5 | C4277690 | |
| Disease | amnestic disorder (implicated_via_orthology) | 2.40e-03 | 9 | 246 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | eye morphology measurement | 2.45e-03 | 218 | 246 | 7 | EFO_0007858 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.52e-03 | 112 | 246 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Head and Neck Neoplasms | 2.60e-03 | 33 | 246 | 3 | C0018671 | |
| Disease | non-high density lipoprotein cholesterol measurement | GAS6 WDR81 ADD1 NPFFR2 SSH1 CACNA1A GLIS3 DGKZ IGF2R OIT3 ERGIC3 HYDIN PLCE1 DNAH11 | 2.82e-03 | 713 | 246 | 14 | EFO_0005689 |
| Disease | triacylglycerol 54:1 measurement | 2.98e-03 | 10 | 246 | 2 | EFO_0010419 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 2.98e-03 | 10 | 246 | 2 | cv:CN043592 | |
| Disease | Autoinflammatory disorder | 3.08e-03 | 35 | 246 | 3 | C3860213 | |
| Disease | migraine disorder, endometriosis | 3.27e-03 | 73 | 246 | 4 | EFO_0001065, MONDO_0005277 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.34e-03 | 293 | 246 | 8 | C1708349 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 3.61e-03 | 37 | 246 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.62e-03 | 11 | 246 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 3.62e-03 | 11 | 246 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | Stomach Neoplasms | 3.63e-03 | 297 | 246 | 8 | C0038356 | |
| Disease | mucocutaneous lymph node syndrome | 3.78e-03 | 76 | 246 | 4 | EFO_0004246 | |
| Disease | Malignant neoplasm of stomach | 3.86e-03 | 300 | 246 | 8 | C0024623 | |
| Disease | opioid dependence | 3.88e-03 | 237 | 246 | 7 | EFO_0005611 | |
| Disease | Manic | 4.15e-03 | 78 | 246 | 4 | C0338831 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 4.32e-03 | 12 | 246 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Amelogenesis Imperfecta | 4.32e-03 | 12 | 246 | 2 | C0002452 | |
| Disease | Nonsyndromic Deafness | 4.75e-03 | 81 | 246 | 4 | C3711374 | |
| Disease | Cutaneous Melanoma | 4.83e-03 | 41 | 246 | 3 | C0151779 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.83e-03 | 41 | 246 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.83e-03 | 41 | 246 | 3 | C0858252 | |
| Disease | Mammary Carcinoma, Human | RPS6KB2 BCHE ADAR BAP1 ALDOA DYNC2H1 BIRC2 XRCC3 SLC22A18 KMT2D MTR | 4.84e-03 | 525 | 246 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | RPS6KB2 BCHE ADAR BAP1 ALDOA DYNC2H1 BIRC2 XRCC3 SLC22A18 KMT2D MTR | 4.84e-03 | 525 | 246 | 11 | C1257931 |
| Disease | polyunsaturated fatty acid measurement | 4.91e-03 | 131 | 246 | 5 | EFO_0010733 | |
| Disease | Mammary Neoplasms | RPS6KB2 BCHE ADAR BAP1 ALDOA DYNC2H1 BIRC2 XRCC3 SLC22A18 KMT2D MTR | 4.98e-03 | 527 | 246 | 11 | C1458155 |
| Disease | colon carcinoma (is_marker_for) | 5.08e-03 | 13 | 246 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Migraine Disorders | 5.08e-03 | 13 | 246 | 2 | C0149931 | |
| Disease | Adverse reaction to drug | 5.40e-03 | 84 | 246 | 4 | C0041755 | |
| Disease | Drug toxicity | 5.40e-03 | 84 | 246 | 4 | C0013221 | |
| Disease | Malignant Head and Neck Neoplasm | 5.89e-03 | 44 | 246 | 3 | C0278996 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 5.90e-03 | 14 | 246 | 2 | C1858991 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 6.35e-03 | 197 | 246 | 6 | EFO_0005680 | |
| Disease | Colorectal Carcinoma | ADARB2 PTPRS UNC13B FLNC SATB2 RET CUBN CDH22 ERGIC3 PANK4 TENM1 LRP1 MTRR | 6.36e-03 | 702 | 246 | 13 | C0009402 |
| Disease | African Burkitt's lymphoma | 6.77e-03 | 15 | 246 | 2 | C0343640 | |
| Disease | Lymphoma, Large-Cell, Follicular | 6.77e-03 | 15 | 246 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 6.77e-03 | 15 | 246 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 6.77e-03 | 15 | 246 | 2 | C0079758 | |
| Disease | Peroxisome biogenesis disorders | 6.77e-03 | 15 | 246 | 2 | C1832200 | |
| Disease | N-acetylmethionine measurement | 6.77e-03 | 15 | 246 | 2 | EFO_0021427 | |
| Disease | Burkitt Leukemia | 6.77e-03 | 15 | 246 | 2 | C4721444 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDESPGLYGFLHVIV | 496 | Q12979 | |
| GPIALDDVEYLAGQH | 1121 | Q6UXC1 | |
| IDLGLVLHQGAYFRD | 1296 | O00555 | |
| LIFLVTGIHGDPYNA | 366 | Q15303 | |
| EGANLFIYHLPQEFG | 421 | O95319 | |
| HGYEIEFVFGLPLER | 466 | P06276 | |
| QLDDYLGGSPVQHRE | 81 | O75366 | |
| FHIASREGDPLILQY | 141 | Q6P6B7 | |
| LVYVHRGGPAQDLTF | 626 | Q6UVK1 | |
| LGVGDIPYNDFHVRG | 56 | P59827 | |
| PEFRYTAGIHGNEVL | 616 | Q8IUX7 | |
| YAGGVVLHPRTISLE | 291 | Q99965 | |
| NPCIGGVILFHETLY | 71 | P04075 | |
| LLGPLDVHAGSYQIE | 951 | Q6V0I7 | |
| RDGNPIIVYLHGSAE | 136 | Q7Z5M8 | |
| KLPHRVDGTGFVVYD | 201 | Q9HAR2 | |
| DLHPISGYLEFRQGE | 1506 | Q8WXG9 | |
| LFFYRQTLPDGHLTD | 676 | Q8TCU4 | |
| QHRYLQGVPEGVRDL | 221 | Q5T440 | |
| EEEGRLHSIQGLYGL | 1821 | Q8IYW2 | |
| LYGLHPNAEIEFLTV | 4206 | Q96DT5 | |
| QAENIGYDPERGTHL | 696 | Q9ULD4 | |
| LATAGEPYHDIRFNL | 216 | Q92560 | |
| PCRELEQLHLGLYGT | 406 | Q8N531 | |
| HGPRFRLEGNAVLYG | 306 | P19801 | |
| GRFTGHPGAYLRLIN | 616 | Q32M45 | |
| LIYIAFILGRINGHP | 436 | A1A5B4 | |
| SLVVHGPGDLRLENY | 11 | Q00796 | |
| NGLLDRENPLYSHGF | 296 | Q9H251 | |
| QPALRGLSLDFYQGH | 821 | Q8IZY2 | |
| GQYESILDALFRLHG | 311 | A0A1B0GUU1 | |
| GFIAPTRHGYLIREN | 1486 | Q149M9 | |
| TIYPGTFRHLQALEE | 96 | Q86UN3 | |
| YGRIGISLFRAAVPH | 341 | Q9Y5X5 | |
| HLPDRREIISFGSGY | 221 | P35558 | |
| GLQGALLSHFVEPVY | 566 | Q9NS39 | |
| SVQAVGAPGLRHFLY | 401 | Q7L1V2 | |
| FVLYPNGALEGRVHA | 471 | O75106 | |
| EVQAGYPRGIHTLGF | 366 | P09238 | |
| HGVPDTTDLLINFRY | 1206 | Q12913 | |
| FIYLRPGSRDALHGV | 256 | Q8NGN6 | |
| PGSRDALHGVVAVFY | 261 | Q8NGN6 | |
| PEVPLGQLHDSYRAF | 1236 | Q14667 | |
| ALHILDGPEQRYFLG | 331 | Q5T9C9 | |
| GVLHVPITRSGDLSY | 2931 | Q86XX4 | |
| IVYSGRELNHPFGLS | 731 | Q9NZR2 | |
| RHSLSPEEYIFGALN | 281 | Q9BWQ8 | |
| HYIPIRVLGRGAFGE | 51 | Q8TD19 | |
| ATPHYFALIDQLIEG | 256 | Q16706 | |
| FRLPSANVYGLGEHV | 211 | Q2M2H8 | |
| HLDSPNIGVYEGDRV | 546 | Q02846 | |
| RLVPGDRFHYINGSL | 121 | P61968 | |
| DTSHGLRNLYFLDPI | 911 | Q38SD2 | |
| RVFQLHPDGTVRYGI | 161 | Q9UN88 | |
| LIPEYLNFIHGVVDS | 311 | Q58FF7 | |
| GPHLRFYLDGGSLVL | 3271 | Q8NDA2 | |
| LEIGQALPIHAGRYT | 3906 | Q8NDA2 | |
| SFLLYSVHEGIRGIP | 1891 | Q07954 | |
| LDEDTIYHLQPSGRF | 236 | P31153 | |
| IGLHLRGGYIFPTQQ | 811 | O43451 | |
| LPVDFFAHLRYGLLG | 81 | Q9UBK8 | |
| YIHPFIDGNGRTSRL | 361 | Q9BVA6 | |
| YELGHVLANDGPVRQ | 736 | Q8ND23 | |
| LGADNIDVSHPIIYR | 336 | Q9UK73 | |
| GGHILPYDQPLRAFD | 446 | Q9H3G5 | |
| NIYRGPEVSLGHGSI | 341 | Q13144 | |
| HILARLFERYGSPGN | 266 | O95373 | |
| GNLVHAAYFLLVGIP | 16 | Q8NGF3 | |
| YVPLIGLSVVHRFGN | 251 | Q9H255 | |
| LYFGIEPVVHVSGLE | 416 | Q8WWZ8 | |
| YGALAEFHVQRVLLP | 156 | Q7Z412 | |
| VRQPVFELLGHTYAI | 231 | O00628 | |
| IQHLSFGEDYPGIVN | 246 | Q9Y282 | |
| PGEYTINILFAEAHI | 1126 | Q14315 | |
| YPVHGFLQRDLFNGI | 581 | Q5H8C1 | |
| GEGRPLEVFQYEHIL | 1986 | Q9HD67 | |
| NELGFHYTASGPLVR | 336 | O43766 | |
| GAFDGNPLLRTIHLY | 266 | Q9BXB1 | |
| ILRGIFSVPGGHNLY | 436 | Q96PP9 | |
| LFYTIAEGQERIPIH | 76 | Q9UI32 | |
| LAEGHLDGQPFLRYD | 46 | Q29980 | |
| GLHTERGADPVIGLY | 66 | A4D2B8 | |
| NVSHTGVPLGEEYIL | 276 | Q8NAT1 | |
| FGPRLIQLDDVTYHG | 166 | O15527 | |
| PITYGEEQLLHFLGQ | 3691 | Q9Y4D8 | |
| DFRGQQFILEHGDYP | 56 | Q8WXF5 | |
| PDIIVGHNIYGFELE | 631 | P09884 | |
| AGLEPYFDFIITIGH | 31 | Q9BQQ3 | |
| RLGDPAEYAHLVQAI | 226 | Q99714 | |
| TIGYADVHGDLLPIN | 61 | Q9BYG4 | |
| RAYSPGIQGLHEEII | 211 | Q5XG87 | |
| EHLLRGLVYPSEGIQ | 181 | Q5TIA1 | |
| FRNSLGLIYAIHVEG | 146 | O95248 | |
| HRRSLGVYLQEGPVG | 1706 | O95248 | |
| FGTELLHYQLGPDID | 256 | Q96BW5 | |
| FDNRGLEPGHRYVLF | 1231 | Q13332 | |
| GEVQALFLRHEGYLG | 346 | Q9NVE7 | |
| VIPAHYVRLGGEAGA | 541 | A8MVW0 | |
| GEDHPRQGSILYSLL | 136 | P51843 | |
| HRELYFGVDLPSGNL | 61 | Q9H158 | |
| QIPGLDVLLGYTDAH | 51 | Q9NPB6 | |
| GQFTDEYLPEQRSHL | 1346 | Q14112 | |
| FIRIYPERATHGGLG | 561 | O14786 | |
| FEALHNLEPRGYVVG | 966 | Q13797 | |
| GQGIVYETFHLSDLP | 416 | Q02218 | |
| HSRCNFDVLEIYGGP | 1441 | O60494 | |
| IYGGPDFHSPRIAQL | 1451 | O60494 | |
| EFVHGLLENAIYGGR | 3916 | Q8NCM8 | |
| LDLRGEVHYPNLSFE | 1156 | Q4G0P3 | |
| LELGLVQSPDGHRLY | 116 | Q9NP55 | |
| DLIGDPQALNYFLHG | 11 | Q6AI39 | |
| NPVGGLLEYARSHGF | 726 | P55265 | |
| LLGGPRTVSYAVEFH | 661 | Q9NVM4 | |
| GAPSYIHVFRNGDLV | 126 | A2VCK2 | |
| IAPEYRLVIVGHSLG | 431 | Q8NCG7 | |
| RLLHDQVGVIQFGPY | 941 | P53621 | |
| NALRAHAYGLPDGFL | 1611 | Q5JV73 | |
| HAYGLPDGFLAARLD | 1616 | Q5JV73 | |
| TYHDPVLRPGILGNF | 121 | Q86SF2 | |
| AGDLFQPERGLYHLN | 406 | Q14393 | |
| LSPQPEVYGHFLGVR | 186 | Q8NEA6 | |
| RIVGEFLQPGGYHVL | 161 | Q14534 | |
| HDPDLGLGGQVRYSL | 961 | Q8TDW7 | |
| HAVLLVGYGNRSDVP | 431 | Q9UBX1 | |
| GLVHGLPYVADRQGF | 166 | Q16739 | |
| ELGRSPVFLYEDHTG | 131 | P20908 | |
| LGGQALLYGFRVAPH | 151 | Q8N144 | |
| VHTPGVYRDLFGTLQ | 326 | O75426 | |
| PYDGVFIALLVEEGH | 296 | Q5VSG8 | |
| EGHGFLYETFGIRPQ | 131 | Q9Y2E5 | |
| IFCETGYELLQGHLP | 326 | O00187 | |
| QDTFHGYPGITEELL | 21 | Q8N668 | |
| NIHVCLGGLFVPEAY | 4506 | Q14204 | |
| TNRFTLLGILPGHEY | 1096 | Q86VF2 | |
| INDSEPRFLHGPYIG | 161 | Q9UJ99 | |
| IFSGALLYGDPELEH | 1001 | Q9Y6C2 | |
| GQFLLYGHILTPEEI | 1026 | Q9NYC9 | |
| PQRHDDGYLEVIGFT | 551 | Q13574 | |
| RFPELGPDGHQRLDY | 496 | Q6ZRV2 | |
| LRAEGADQLAFYPPH | 221 | Q5T4B2 | |
| RGSSHQVEYEILFPG | 286 | O76054 | |
| RGSSHQVEYEILFPG | 286 | Q9UDX4 | |
| IYVGIVFLGFTPDHR | 36 | O15244 | |
| NVLRHEAEFYGITPL | 91 | Q9Y597 | |
| NGDVGPLSHRQDYEL | 2116 | Q01668 | |
| HYSELIQFGVGERPQ | 821 | P20273 | |
| ALRHGADLVPIYSFG | 266 | Q96PD7 | |
| EPFINEGKRLGYIHR | 891 | Q08211 | |
| DVALPVPYDHQRGFS | 166 | P09619 | |
| VPYHATGLLGFVRQV | 1066 | P28827 | |
| SLRYFRLGVSDPIHG | 26 | Q95460 | |
| LHIVARLFERYGSPG | 266 | O15397 | |
| PLYDGLQAGAADHVR | 181 | Q96C03 | |
| PGSRDYLQLTEHGNV | 586 | Q9H720 | |
| QEGRYPRLENVGLHF | 216 | A0A1W2PRP0 | |
| VDLSPLIHRTGGYEA | 1661 | P11717 | |
| PEPGNLGLTVYHRAF | 331 | Q5T011 | |
| SIGGALRYVLNNHPE | 1441 | Q5TCS8 | |
| GSFANLRIYPHGLVL | 56 | P52788 | |
| ETLQHRRYPNVFGIG | 321 | Q9Y6N5 | |
| LPGAEHFAEYAGRLG | 76 | P25325 | |
| SERYNGFVLPCLGVH | 56 | Q17R31 | |
| RHPASGYVQGINDLV | 301 | Q9NU19 | |
| QTLPYVGFLEHIGRI | 196 | Q9H5Y7 | |
| RRLHGLPEQFLYGTA | 696 | Q02880 | |
| FLGFRTLPHYEEGSL | 171 | Q9BXR5 | |
| SVLGQRLDLPEDFHY | 796 | Q9ULQ0 | |
| YERDLEPHSFGGLLE | 96 | Q9Y3Q8 | |
| LAELRAAGLEPVGHY | 31 | Q9UBS0 | |
| LEYIPDGAFDHLVGL | 161 | Q8TF66 | |
| ILARYALNHPDTVEG | 151 | Q9UN36 | |
| LNPGLEYLVAGHEDI | 581 | Q9HB63 | |
| RYEGPTLAHAVELFG | 1036 | Q9P212 | |
| GPGDIKAFQVLYREH | 601 | P22670 | |
| ALRTFGHLLRYGEPT | 671 | Q13200 | |
| TLEYFPSELGGLRHA | 166 | Q9UGC7 | |
| REVLQFVGLSHQYPG | 1411 | Q8IVG5 | |
| LHIFPSIYDVFGGVI | 366 | Q8TBE7 | |
| YDDNGEGIILFRPSH | 196 | P30101 | |
| GRSYLHIPQDVGVNL | 251 | O60508 | |
| HIGVGEPDFILGQLY | 1591 | Q96Q15 | |
| GELRQYLEHGLETTP | 1801 | Q96Q15 | |
| IAPLHSGIRDYLGLF | 1086 | Q99707 | |
| YELGQGHAQASPEIR | 141 | Q9NZC9 | |
| LGILQSFIHDVGLYP | 626 | Q9UPW6 | |
| ARALVAFHQGIYPEL | 151 | Q9UIU6 | |
| GPNIDAHDYVFRLNG | 166 | Q9UJ37 | |
| NSPRGITVDRHGFIY | 1306 | Q9UKZ4 | |
| LGLHQQGSEPSYLDR | 361 | Q9BV38 | |
| ETAPAVLERHQGALY | 121 | Q15493 | |
| VLERHQGALYSLFPD | 126 | Q15493 | |
| SGRVEYVFGDHPLIQ | 251 | P42338 | |
| HLQQSYLPRGTGEFD | 391 | Q8NA69 | |
| LHREDFRGYALGQVP | 221 | Q7Z745 | |
| PLYAAFQEGLLRVTH | 246 | Q7RTU9 | |
| LLYRSFGVPVFGHVQ | 386 | Q96BI1 | |
| FLYEFLLQGHTSEPR | 281 | Q9HCE7 | |
| VARRHNYFPGGVALI | 191 | Q8WYL5 | |
| GQEFVDEIQGRYPHL | 341 | Q13490 | |
| DLYGHLRSFLLPEVG | 11 | P34969 | |
| GPRTAVFHGLLTEAY | 146 | O95561 | |
| EQEHFLIVPFGLLYS | 176 | P35611 | |
| GGPLDGTYRLIQFHF | 81 | P00918 | |
| AAHLYLGRPQDFIGG | 221 | Q8IZ52 | |
| IYGFLGIPLDSHVAR | 316 | O43916 | |
| LPGEFYITRHSNLSE | 411 | Q9NQ89 | |
| IYGHLDVQPAALEDG | 96 | Q96KP4 | |
| FPGVLENRDHYGRKI | 126 | Q8IUQ0 | |
| HINSPGDFYLQLIEG | 686 | Q9BXT8 | |
| DNLGIRIPVGHVDYF | 221 | Q53H76 | |
| LLRGYVGSIQPHGVF | 1326 | Q14690 | |
| GTYRQLFHPEQLITG | 81 | P0DPH8 | |
| TTELEPYLHGGIAVQ | 276 | A0AVT1 | |
| REAIYNFGGISHPKE | 201 | Q5JXA9 | |
| ALAGVGPVLHSFRVY | 216 | Q86UP3 | |
| YNLTFHVGGLPLRFD | 431 | Q7RTX0 | |
| PRRVGIFLDYEAGHL | 401 | Q96F44 | |
| GTFRDLGDSHPVLYQ | 646 | Q05086 | |
| ALFHGTVLRYVGTPQ | 36 | Q969K7 | |
| GTDYRLHLSPVQIFD | 226 | P40200 | |
| SIHQFEVGPYGCILL | 556 | Q4G0A6 | |
| DLTFVHLGNPDYIDG | 991 | Q13905 | |
| PGDADQEIYFIHGLF | 121 | Q0VAA5 | |
| EGRGHLLYVALSPGQ | 846 | O15067 | |
| HGRVGIFPRTYIELL | 836 | Q9BX66 | |
| RIELQDDGYHAPGAF | 386 | A6NK02 | |
| GTYRQLFHPEQLITG | 81 | P0DPH7 | |
| SGEHFRSLLGYDPQI | 221 | O95073 | |
| TGLAPGQEYEISLHI | 771 | P24821 | |
| LAGEQYHEVLVPRGI | 631 | Q92752 | |
| LGRVLEAGTLPHYFL | 441 | Q8N9M5 | |
| EAGTLPHYFLNGRQL | 446 | Q8N9M5 | |
| SDFDGGVYHGRIVLP | 51 | Q9Y385 | |
| LYLDGHVFASQPRLV | 1926 | Q5JSZ5 | |
| VQRHLPFEGGLAYGI | 1846 | Q9NY15 | |
| DFQLVIGFHGGLYDP | 2331 | Q9P273 | |
| HFLLGNEEGPESYEL | 1496 | O14795 | |
| AIEYAPHGNLLDFLR | 901 | Q02763 | |
| VLVPRFLTNAYDIGH | 296 | Q14997 | |
| IRHPASGYVQGINDL | 311 | Q8WUA7 | |
| TPHGLFILFGVYGDV | 371 | O95758 | |
| EEVPSFRLGQHLYGT | 61 | P07949 | |
| PLYAAFQEGLLRVTH | 246 | A6NGW2 | |
| LGYTLCGLRPEELQH | 1591 | A6NGW2 | |
| GTYRQLFHPEQLITG | 81 | Q71U36 | |
| GTYRQLFHPEQLITG | 81 | Q6PEY2 | |
| LSSGPEFQLLRYHID | 616 | A2RRH5 | |
| GRSANFLDHLYVGIP | 506 | Q8TB96 | |
| FLDHLYVGIPRPSGE | 511 | Q8TB96 | |
| GTYRQLFHPEQLITG | 81 | P68363 | |
| GAQLRLGIYDADPAH | 556 | P0DP72 | |
| VDAVHPGYGFLSERA | 111 | P11498 | |
| GTYRQLFHPEQLITG | 81 | Q9BQE3 | |
| FPRQHGGLEAGAVYI | 126 | O43542 | |
| LIGAYESPCQLHGRF | 966 | Q562E7 | |
| GTYRQLFHPEQLITG | 81 | Q9NY65 | |
| DEIRNGPYRQLFHPE | 76 | P68366 | |
| GYVRIVEAILNHPGF | 101 | Q13507 | |
| LIAEIAFQYRHGDPI | 236 | P07101 | |
| NLLYAVGGHDGPLVR | 496 | O95198 | |
| IDATLTGGPARYINH | 5461 | O14686 | |
| HGNLFVFPNGTLYIR | 2096 | Q9NR99 | |
| HLQGFEPPGYERTEL | 26 | P15173 |